(+)-(S)-ar-turmerone increases expression ISO RGD:70502 6480464 ar-turmerone results in increased expression of TP53 mRNA, ar-turmerone results in increased expression of TP53 protein CTD PMID:19250610 (+)-artemisinin increases activity ISO RGD:70502 6480464 artemisinin results in increased activity of TP53 protein CTD PMID:30818834 (+)-catechin multiple interactions EXP 6480464 Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of TRP53 protein] CTD PMID:15879681 (+)-catechin multiple interactions ISO RGD:3889 6480464 Catechin inhibits the reaction [Rotenone results in increased expression of TP53 mRNA] CTD PMID:35337893 (+)-catechin increases expression ISO RGD:70502 6480464 Catechin results in increased expression of TP53 mRNA, Catechin results in increased expression of TP53 protein CTD PMID:23706674 (+)-dexrazoxane multiple interactions EXP 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in increased expression of TRP53 mRNA] CTD PMID:28973540 (+)-epicatechin-3-O-gallate multiple interactions EXP 6480464 epicatechin gallate promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 mRNA] CTD PMID:18656336 (+)-schisandrin B multiple interactions EXP 6480464 [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein], [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of TRP53 protein] CTD PMID:22003191 (+)-schisandrin B multiple interactions ISO RGD:3889 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TP53 mRNA] CTD PMID:31150632 (-)-alpha-phellandrene increases expression EXP 6480464 alpha phellandrene results in increased expression of TRP53 protein modified form CTD PMID:24861204 (-)-alpha-phellandrene decreases expression EXP 6480464 alpha phellandrene results in decreased expression of TRP53 protein CTD PMID:24861204 (-)-alpha-phellandrene affects localization ISO RGD:70502 6480464 alpha phellandrene affects the localization of TP53 protein CTD PMID:25649747 (-)-alpha-phellandrene increases phosphorylation EXP 6480464 alpha phellandrene results in increased phosphorylation of TRP53 protein CTD PMID:24861204 (-)-anisomycin multiple interactions ISO RGD:3889 6480464 Anisomycin promotes the reaction [Colistin results in increased expression of TP53 protein] CTD PMID:28842171 (-)-citrinin increases expression ISO RGD:70502 6480464 Citrinin results in increased expression of TP53 protein CTD PMID:20929984 (-)-citrinin increases expression ISO RGD:3889 6480464 Citrinin results in increased expression of TP53 protein modified form CTD PMID:22564900 (-)-citrinin increases expression EXP 6480464 Citrinin results in increased expression of TRP53 protein CTD PMID:21622943 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:70502 6480464 epigallocatechin gallate affects the reaction [Doxorubicin affects the expression of TP53 protein] more ... CTD PMID:15657356 more ... (-)-epigallocatechin 3-gallate increases expression ISO RGD:70502 6480464 epigallocatechin gallate results in increased expression of TP53 protein, epigallocatechin gallate results in increased expression of TP53 protein modified form CTD PMID:26341291 , PMID:32512070 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:3889 6480464 [epigallocatechin gallate co-treated with coenzyme Q10] inhibits the reaction [Cisplatin results in increased phosphorylation of TP53 protein] CTD PMID:33393703 (-)-epigallocatechin 3-gallate increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to epigallocatechin gallate CTD PMID:15764647 , PMID:23285096 (-)-epigallocatechin 3-gallate affects response to substance ISO RGD:70502 6480464 TP53 mRNA affects the susceptibility to epigallocatechin gallate CTD PMID:19406223 (-)-epigallocatechin 3-gallate affects expression ISO RGD:3889 6480464 epigallocatechin gallate affects the expression of TP53 protein CTD PMID:22000973 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9 more ... CTD PMID:18656336 more ... (-)-noscapine increases expression ISO RGD:70502 6480464 Noscapine results in increased expression of TP53 protein CTD PMID:20674069 (-)-noscapine multiple interactions ISO RGD:70502 6480464 Noscapine promotes the reaction [Cisplatin results in increased expression of TP53 protein], Noscapine results in increased expression of and results in increased phosphorylation of TP53 protein CTD PMID:20674069 , PMID:22848370 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TRP53 mRNA CTD PMID:36331819 (1S)-bornane-2,3-dione increases phosphorylation ISO RGD:70502 6480464 camphorquinone results in increased phosphorylation of TP53 protein CTD PMID:26658076 (20R)-protopanaxadiol increases expression ISO RGD:70502 6480464 protopanaxadiol results in increased expression of TP53 mRNA, protopanaxadiol results in increased expression of TP53 protein CTD PMID:31805304 (6aR,11aS,11bR)-10-acetyl-11-hydroxy-7,7-dimethyl-2,6,6a,7,11a,11b-hexahydro-9H-pyrrolo[1',2':2,3]isoindolo[4,5,6-cd]indol-9-one increases expression EXP 6480464 cyclopiazonic acid results in increased expression of TRP53 mRNA CTD PMID:33400354 (9E,11E)-octadecadienoic acid multiple interactions ISO RGD:70502 6480464 9, 11-linoleic acid results in increased phosphorylation of and affects the localization of TP53 protein CTD PMID:15992797 (aminomethyl)phosphonic acid increases expression ISO RGD:70502 6480464 1-aminomethylphosphonic acid results in increased expression of TP53 protein CTD PMID:23983455 (R)-adrenaline decreases expression EXP 6480464 Epinephrine results in decreased expression of TP53 protein CTD PMID:36423730 (R)-lipoic acid multiple interactions ISO RGD:3889 6480464 Thioctic Acid inhibits the reaction [Methotrexate results in increased expression of TP53 protein] CTD PMID:19900424 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:70502 6480464 alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 mRNA], alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 protein] CTD PMID:12126965 (S)-colchicine multiple interactions ISO RGD:70502 6480464 TP53 protein affects the reaction [Colchicine results in increased phosphorylation of JUN protein] more ... CTD PMID:12221076 (S)-naringenin multiple interactions ISO RGD:70502 6480464 [Tamoxifen co-treated with naringenin] results in increased expression of TP53 mRNA more ... CTD PMID:15795422 more ... (S)-naringenin increases expression ISO RGD:70502 6480464 naringenin results in increased expression of TP53 mRNA CTD PMID:30153467 (S)-nicotine multiple interactions ISO RGD:70502 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of TP53 protein] more ... CTD PMID:16601104 more ... (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of TRP53 mRNA, Nicotine results in increased expression of TRP53 protein CTD PMID:30896085 , PMID:31507073 (S)-nicotine increases expression ISO RGD:70502 6480464 Nicotine results in increased expression of TP53 protein CTD PMID:20727180 (S)-nicotine decreases expression ISO RGD:70502 6480464 Nicotine results in decreased expression of TP53 mRNA, Nicotine results in decreased expression of TP53 protein CTD PMID:16011614 more ... (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of TRP53 protein CTD PMID:18835254 (S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with Polylactic Acid-Polyglycolic Acid Copolymer] inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23933227 , PMID:30896085 (S)-nicotine increases expression ISO RGD:3889 6480464 Nicotine results in increased expression of TP53 mRNA CTD PMID:20339300 , PMID:20426880 (S)-nicotine affects response to substance ISO RGD:3889 6480464 TP53 protein affects the susceptibility to Nicotine CTD PMID:15983034 (S)-nicotine affects expression ISO RGD:3889 6480464 Nicotine affects the expression of TP53 mRNA CTD PMID:10837795 (S)-ropivacaine multiple interactions ISO RGD:3889 6480464 pifithrin inhibits the reaction [Ropivacaine results in increased expression of TP53 mRNA], pifithrin inhibits the reaction [Ropivacaine results in increased expression of TP53 protein] CTD PMID:34091999 (S)-ropivacaine increases expression ISO RGD:3889 6480464 Ropivacaine results in increased expression of TP53 mRNA, Ropivacaine results in increased expression of TP53 protein CTD PMID:34091999 (Z)-3-butylidenephthalide increases expression ISO RGD:70502 6480464 butylidenephthalide results in increased expression of TP53 protein CTD PMID:16987298 (Z)-3-butylidenephthalide increases phosphorylation ISO RGD:70502 6480464 butylidenephthalide results in increased phosphorylation of TP53 protein CTD PMID:16987298 (Z)-ligustilide multiple interactions ISO RGD:70502 6480464 ligustilide results in decreased expression of and results in increased phosphorylation of TP53 protein CTD PMID:31765699 1'-acetoxychavicol acetate multiple interactions ISO RGD:70502 6480464 [1'-acetoxychavicol acetate co-treated with Butyric Acid] results in increased phosphorylation of TP53 protein CTD PMID:24480522 1,1'-azobis(N,N-dimethylformamide) increases glutathionylation ISO RGD:70502 6480464 Diamide results in increased glutathionylation of TP53 protein CTD PMID:17555331 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:3889 6480464 o more ... CTD PMID:22937105 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of TRP53 protein CTD PMID:26682919 1,10-phenanthroline affects folding EXP 6480464 1, 10-phenanthroline affects the folding of TRP53 protein CTD PMID:8467489 1,10-phenanthroline affects activity ISO RGD:70502 6480464 1, 10-phenanthroline analog affects the activity of TP53 protein CTD PMID:35435491 1,2-dichloroethane affects expression EXP 6480464 ethylene dichloride affects the expression of TRP53 mRNA, ethylene dichloride affects the expression of TRP53 protein CTD PMID:28973639 1,2-dimethylhydrazine decreases methylation ISO RGD:3889 6480464 1, 2-Dimethylhydrazine results in decreased methylation of TP53 exon CTD PMID:8863662 1,2-dimethylhydrazine affects expression EXP 6480464 1, 2-Dimethylhydrazine affects the expression of TRP53 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of TRP53 mRNA CTD PMID:26388957 1,2-dimethylhydrazine increases expression ISO RGD:3889 6480464 1, 2-Dimethylhydrazine results in increased expression of TP53 protein CTD PMID:18155637 1,2-dimethylhydrazine multiple interactions ISO RGD:3889 6480464 Folic Acid inhibits the reaction [1 more ... CTD PMID:18155637 , PMID:8863662 1,3-Dinitropyrene increases phosphorylation EXP 6480464 1, 3-dinitropyrene results in increased phosphorylation of TRP53 protein CTD PMID:17240030 1,3-Dinitropyrene affects localization EXP 6480464 1, 3-dinitropyrene affects the localization of TRP53 protein CTD PMID:17240030 1,4-benzoquinone increases expression ISO RGD:70502 6480464 quinone results in increased expression of TP53 protein CTD PMID:20499891 1,4-benzoquinone increases expression EXP 6480464 quinone analog results in increased expression of TRP53 protein modified form CTD PMID:33961949 1,4-benzoquinone multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [quinone analog results in increased expression of TRP53 protein modified form] more ... CTD PMID:33961949 1,4-dithiothreitol multiple interactions ISO RGD:70502 6480464 Dithiothreitol inhibits the reaction [[Cadmium Chloride results in decreased activity of TP53 protein] inhibits the reaction [TP53 protein binds to TP53 gene]] more ... CTD PMID:17555331 , PMID:25446071 1,8-Dinitropyrene increases phosphorylation EXP 6480464 1, 8-dinitropyrene results in increased phosphorylation of TRP53 protein CTD PMID:17240030 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression EXP 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:23933227 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions EXP 6480464 [Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23933227 1-methylphenanthrene increases phosphorylation ISO RGD:3889 6480464 1-methylphenanthrene results in increased phosphorylation of TP53 protein CTD PMID:17941746 1-naphthyl isothiocyanate increases expression ISO RGD:3889 6480464 1-Naphthylisothiocyanate results in increased expression of TP53 mRNA CTD PMID:17522070 1-nitropyrene multiple interactions ISO RGD:70502 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased susceptibility to [Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of TP53 protein]] more ... CTD PMID:10837373 , PMID:22044530 1-nitropyrene decreases expression EXP 6480464 1-nitropyrene results in decreased expression of TRP53 mRNA CTD PMID:11911274 1-nitropyrene affects localization EXP 6480464 1-nitropyrene affects the localization of TRP53 protein CTD PMID:17240030 1-nitropyrene affects response to substance ISO RGD:70502 6480464 TP53 affects the susceptibility to 1-nitropyrene CTD PMID:10837373 1-nitropyrene increases expression ISO RGD:70502 6480464 1-nitropyrene results in increased expression of TP53 protein, 1-nitropyrene results in increased expression of TP53 protein modified form CTD PMID:10837373 , PMID:22044530 1-nitropyrene increases phosphorylation EXP 6480464 1-nitropyrene results in increased phosphorylation of TRP53 protein CTD PMID:17240030 1-nitropyrene increases expression EXP 6480464 1-nitropyrene results in increased expression of TRP53 mRNA CTD PMID:10928071 , PMID:11911274 1-nitropyrene affects expression ISO RGD:3889 6480464 1-nitropyrene affects the expression of TP53 mRNA CTD PMID:11201684 11-deoxycorticosterone multiple interactions ISO RGD:3889 6480464 [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein more ... CTD PMID:22431579 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of TRP53 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects activity ISO RGD:70502 6480464 Ethinyl Estradiol affects the activity of TP53 protein CTD PMID:35435491 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRP53 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:3889 6480464 Ethinyl Estradiol results in increased expression of TP53 mRNA CTD PMID:16940010 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of TRP53 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:70502 6480464 [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with Decitabine] results in increased expression of TP53 protein more ... CTD PMID:15870704 more ... 17beta-estradiol decreases expression ISO RGD:70502 6480464 Estradiol results in decreased expression of TP53 mRNA CTD PMID:31016752 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of TRP53 protein CTD PMID:23684557 17beta-estradiol multiple interactions EXP 6480464 Estradiol inhibits the reaction [TRP53 protein binds to CDKN1A promoter] CTD PMID:23684557 17beta-estradiol increases expression ISO RGD:70502 6480464 Estradiol results in increased expression of TP53 mRNA, Estradiol results in increased expression of TP53 protein CTD PMID:18174961 more ... 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of TRP53 mRNA, Estradiol results in increased expression of TRP53 protein CTD PMID:22314386 17beta-estradiol affects expression ISO RGD:70502 6480464 Estradiol affects the expression of TP53 mRNA, Estradiol affects the expression of TRP53 mRNA CTD PMID:11896290 , PMID:22574217 17beta-estradiol increases expression ISO RGD:3889 6480464 Estradiol results in increased expression of TP53 mRNA, Estradiol results in increased expression of TP53 protein CTD PMID:14685795 , PMID:17522070 17beta-estradiol decreases expression ISO RGD:3889 6480464 Estradiol results in decreased expression of TP53 protein CTD PMID:24894866 17beta-estradiol multiple interactions ISO RGD:3889 6480464 [Estradiol co-treated with Methylnitrosourea co-treated with Progesterone] results in decreased expression of TP53 mRNA, resveratrol inhibits the reaction [Estradiol results in decreased expression of TP53 protein] CTD PMID:20732338 , PMID:24894866 17beta-estradiol 3-benzoate increases expression ISO RGD:3889 6480464 estradiol 3-benzoate results in increased expression of TP53 mRNA, estradiol 3-benzoate results in increased expression of TP53 protein CTD PMID:24316378 17beta-estradiol 3-benzoate multiple interactions ISO RGD:3889 6480464 Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of TP53 mRNA], Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of TP53 protein] CTD PMID:24316378 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:70502 6480464 [Curcumin co-treated with Metribolone] results in increased phosphorylation of TP53 protein, TP53 protein inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] CTD PMID:17202838 , PMID:21134073 19-Nor-17alpha-pregn-5(10)-en-20-yne-3alpha,17beta-diol increases expression ISO RGD:3889 6480464 17alpha-ethynylestr-5(10)-ene-3alpha, 17beta-diol results in increased expression of TP53 protein CTD PMID:16019103 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one multiple interactions ISO RGD:70502 6480464 1H-(1 more ... CTD PMID:16288207 1H-pyrazole increases expression EXP 6480464 pyrazole results in increased expression of TRP53 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:70502 6480464 2 more ... CTD PMID:20840854 , PMID:24954032 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',4,4',5,5'-hexachlorobiphenyl increases activity ISO RGD:70502 6480464 2 more ... CTD PMID:27589886 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:3889 6480464 2 more ... CTD PMID:33581290 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:3889 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-Tetrachlorobenzidine affects activity ISO RGD:70502 6480464 2 more ... CTD PMID:35435491 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2'-dithiodiethanol affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to 2-hydroxyethyl disulfide CTD PMID:22926048 2,2,2-tetramine multiple interactions ISO RGD:70502 6480464 Paraquat promotes the reaction [Trientine results in increased phosphorylation of TP53 protein], Trientine results in increased expression of and results in increased activity of TP53 protein CTD PMID:11369509 , PMID:14513838 2,2,2-tetramine increases phosphorylation ISO RGD:70502 6480464 Trientine results in increased phosphorylation of TP53 protein CTD PMID:11369509 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one multiple interactions ISO RGD:70502 6480464 2 more ... CTD PMID:21109480 more ... 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one increases activity ISO RGD:70502 6480464 2 more ... CTD PMID:15860260 , PMID:21647879 2,3,4,6-tetrachlorophenol affects activity ISO RGD:70502 6480464 2 more ... CTD PMID:35435491 2,3,5,6-tetrachlorophenol affects activity ISO RGD:70502 6480464 2 more ... CTD PMID:35435491 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:70502 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased susceptibility to [Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of TP53 protein]] more ... CTD PMID:17070097 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TRP53 mRNA, Tetrachlorodibenzodioxin results in increased expression of TRP53 protein CTD PMID:14718646 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:3889 6480464 Tetrachlorodibenzodioxin affects the expression of TP53 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases phosphorylation EXP 6480464 Tetrachlorodibenzodioxin results in increased phosphorylation of TRP53 protein CTD PMID:19085997 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:3889 6480464 Tetrachlorodibenzodioxin results in increased expression of TP53 mRNA CTD PMID:19520675 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases degradation ISO RGD:3889 6480464 Tetrachlorodibenzodioxin results in increased degradation of TP53 protein CTD PMID:15459018 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:3889 6480464 Tetrachlorodibenzodioxin results in decreased expression of TP53 mRNA, Tetrachlorodibenzodioxin results in decreased expression of TP53 protein CTD PMID:34747641 , PMID:8640813 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:3889 6480464 AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of TP53 protein]] more ... CTD PMID:15093247 , PMID:15459018 2,3,7,8-tetrachlorodibenzodioxine affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:10802220 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TRP53 mRNA CTD PMID:17943652 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of TRP53 mRNA more ... CTD PMID:14708085 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:70502 6480464 Tetrachlorodibenzodioxin results in decreased expression of TP53 mRNA, Tetrachlorodibenzodioxin results in decreased expression of TP53 protein CTD PMID:17070097 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TRP53 mRNA CTD PMID:14708085 more ... 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of TRP53 protein] CTD PMID:22427801 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:3889 6480464 Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of and results in increased activity of TP53 protein], Trinitrobenzenesulfonic Acid results in increased phosphorylation of and results in increased activity of TP53 protein CTD PMID:30503585 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of TRP53 protein CTD PMID:22427801 2,4-D increases expression EXP 6480464 2 more ... CTD PMID:33865415 2,4-D multiple interactions ISO RGD:3889 6480464 [2 more ... CTD PMID:36085217 2,4-D multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with 2 more ... CTD PMID:33865415 2,4-dibromophenol multiple interactions EXP 6480464 2 more ... CTD PMID:33961949 2,4-dibromophenol increases expression EXP 6480464 2, 4-dibromophenol metabolite results in increased expression of TRP53 protein modified form CTD PMID:33961949 2,4-dinitrotoluene affects expression ISO RGD:3889 6480464 2, 4-dinitrotoluene affects the expression of TP53 mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:3889 6480464 Butylated Hydroxytoluene results in increased expression of TP53 mRNA CTD PMID:9780227 2,6-dichloroindophenol multiple interactions ISO RGD:70502 6480464 [2, 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased phosphorylation of TP53 protein CTD PMID:21034357 2,6-dinitrotoluene affects expression ISO RGD:3889 6480464 2, 6-dinitrotoluene affects the expression of TP53 mRNA CTD PMID:21346803 2-acetamidofluorene decreases expression ISO RGD:3889 6480464 2-Acetylaminofluorene results in decreased expression of TP53 protein CTD PMID:19167416 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of TRP53 protein CTD PMID:9667752 2-acetamidofluorene increases response to substance EXP 6480464 TRP53 protein modified form results in increased susceptibility to 2-Acetylaminofluorene CTD PMID:17317680 2-acetamidofluorene multiple interactions EXP 6480464 TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of BAX mRNA] more ... CTD PMID:17317680 2-acetamidofluorene multiple interactions ISO RGD:3889 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of TP53 protein more ... CTD PMID:11003613 more ... 2-acetamidofluorene increases expression ISO RGD:70502 6480464 2-Acetylaminofluorene results in increased expression of TP53 protein CTD PMID:12888115 2-acetamidofluorene increases expression ISO RGD:3889 6480464 2-Acetylaminofluorene results in increased expression of TP53 protein CTD PMID:10708481 more ... 2-amino-4,6-dinitrotoluene increases activity ISO RGD:70502 6480464 2-amino-4, 6-dinitrotoluene results in increased activity of TP53 protein CTD PMID:14577614 2-amino-4,6-dinitrotoluene increases expression ISO RGD:70502 6480464 2-amino-4, 6-dinitrotoluene results in increased expression of TP53 protein CTD PMID:14577614 2-deoxy-D-glucose multiple interactions ISO RGD:70502 6480464 [Deoxyglucose co-treated with demycarosyl-3D-digitoxosylmithramycin SK] results in increased expression of TP53 mRNA more ... CTD PMID:21042727 , PMID:26079942 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid multiple interactions EXP 6480464 [anacardic acid inhibits the reaction [Sodium Fluoride results in increased acetylation of TRP53 protein]] which results in decreased cleavage of CASP3 protein, anacardic acid inhibits the reaction [Sodium Fluoride results in increased acetylation of TRP53 protein] CTD PMID:31927229 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid multiple interactions ISO RGD:70502 6480464 anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein], anacardic acid inhibits the reaction [Genistein promotes the reaction [trichostatin A results in increased acetylation of TP53 protein]] CTD PMID:26768552 , PMID:27129209 2-methoxyethanol increases expression ISO RGD:3889 6480464 methyl cellosolve results in increased expression of TP53 mRNA CTD PMID:19643169 2-naphthylamine decreases expression ISO RGD:70502 6480464 2-Naphthylamine results in decreased expression of TP53 mRNA CTD PMID:18247414 2-nitropropane multiple interactions EXP 6480464 APEX1 protein inhibits the reaction [2-nitropropane results in increased expression of TRP53 protein], POLB protein inhibits the reaction [2-nitropropane results in increased expression of TRP53 protein] CTD PMID:12189182 , PMID:19268524 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of TRP53 protein CTD PMID:12189182 more ... 2-nitrotoluene increases mutagenesis EXP 6480464 2-nitrotoluene results in increased mutagenesis of TRP53 gene CTD PMID:13678655 2-pyridylethylamine multiple interactions ISO RGD:70502 6480464 [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased expression of TP53 protein CTD PMID:17327230 2-tert-butylhydroquinone increases expression ISO RGD:70502 6480464 2-tert-butylhydroquinone results in increased expression of TP53 protein CTD PMID:35123993 2-tert-butylhydroquinone multiple interactions ISO RGD:70502 6480464 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of TP53 protein] CTD PMID:35123993 3',4',7-trihydroxyisoflavone multiple interactions ISO RGD:70502 6480464 3' more ... CTD PMID:22914566 3',4',7-trihydroxyisoflavone increases expression ISO RGD:70502 6480464 3' more ... CTD PMID:22914566 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO RGD:3889 6480464 1 more ... CTD PMID:14993511 , PMID:17035936 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO RGD:3889 6480464 Puromycin Aminonucleoside results in increased expression of TP53 protein CTD PMID:14993511 more ... 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of TRP53 protein CTD PMID:15987750 , PMID:17035936 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions EXP 6480464 1 more ... CTD PMID:15987750 , PMID:17035936 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:70502 6480464 3 more ... CTD PMID:19751709 , PMID:20840854 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:70502 6480464 3 more ... CTD PMID:19751709 , PMID:21703328 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:3889 6480464 tetrabromobisphenol A results in increased expression of TP53 mRNA CTD PMID:28970181 3,3',5,5'-tetrabromobisphenol A increases mutagenesis ISO RGD:3889 6480464 tetrabromobisphenol A results in increased mutagenesis of TP53 gene CTD PMID:26353976 3,3',5,5'-tetraiodothyroacetic acid multiple interactions ISO RGD:3889 6480464 tetraiodothyroacetic acid inhibits the reaction [Thyroxine affects the localization of TP53 protein modified form] CTD PMID:17984113 3,3',5,5'-tetraiodothyroacetic acid decreases expression ISO RGD:70502 6480464 tetraiodothyroacetic acid results in decreased expression of TP53 mRNA CTD PMID:35151786 3,3',5,5'-tetraiodothyroacetic acid multiple interactions ISO RGD:70502 6480464 [heteronemin affects the susceptibility to tetraiodothyroacetic acid] which results in decreased expression of TP53 mRNA more ... CTD PMID:35151786 3,3'-Dichlorobenzidine affects activity ISO RGD:70502 6480464 3, 3'-Dichlorobenzidine affects the activity of TP53 protein CTD PMID:35435491 3,3'-diindolylmethane multiple interactions ISO RGD:70502 6480464 3 more ... CTD PMID:22290291 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine decreases expression ISO RGD:70502 6480464 3 more ... CTD PMID:23810796 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine increases expression ISO RGD:70502 6480464 3 more ... CTD PMID:23810796 3,6-diaminoacridine increases activity ISO RGD:70502 6480464 Proflavine results in increased activity of TP53 protein CTD PMID:30818834 3,6-diaminoacridine affects activity ISO RGD:70502 6480464 Proflavine affects the activity of TP53 protein CTD PMID:35435491 3,7-dihydropurine-6-thione affects activity ISO RGD:70502 6480464 Mercaptopurine affects the activity of TP53 protein CTD PMID:35435491 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:70502 6480464 bisindolylmaleimide I results in decreased degradation of and results in increased expression of TP53 protein CTD PMID:16055726 3-aminobenzamide multiple interactions ISO RGD:70502 6480464 3-aminobenzamide inhibits the reaction [Capsaicin results in increased expression of TP53 protein], 3-aminobenzamide inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein] CTD PMID:22226932 3-BROMO-7-NITROINDAZOLE multiple interactions EXP 6480464 3-bromo-7-nitroindazole inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of TRP53 protein] CTD PMID:23985028 3-bromopyruvic acid multiple interactions ISO RGD:70502 6480464 bromopyruvate promotes the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N more ... CTD PMID:21548882 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone increases mutagenesis ISO RGD:3889 6480464 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone results in increased mutagenesis of TP53 gene CTD PMID:11152562 3-chloropropane-1,2-diol increases expression ISO RGD:70502 6480464 alpha-Chlorohydrin results in increased expression of TP53 protein CTD PMID:28070108 3-hydroxybutyric acid multiple interactions ISO RGD:70502 6480464 3-Hydroxybutyric Acid inhibits the reaction [ERCC6 gene mutant form results in increased acetylation of TP53 protein] CTD PMID:25440059 3-iodoprop-2-yn-1-yl butylcarbamate affects activity ISO RGD:70502 6480464 3-iodo-2-propynylbutylcarbamate affects the activity of TP53 protein CTD PMID:35435491 3-methyladenine multiple interactions ISO RGD:70502 6480464 3-methyladenine inhibits the reaction [[cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CTSB protein] more ... CTD PMID:22927544 more ... 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Caffeine inhibits the reaction [2, 2'-azobis(2-amidinopropane) results in increased phosphorylation of TRP53 protein]] CTD PMID:30555576 3-methylcholanthrene multiple interactions EXP 6480464 Methylcholanthrene promotes the reaction [TRP53 protein binds to ABCB1B promoter] more ... CTD PMID:11096091 , PMID:20570689 3-methylcholanthrene increases expression ISO RGD:3889 6480464 Methylcholanthrene results in increased expression of TP53 mRNA CTD PMID:23273579 3-Nitrobenzanthrone decreases expression ISO RGD:70502 6480464 3-nitrobenzanthrone results in decreased expression of TP53 mRNA, 3-nitrobenzanthrone results in decreased expression of TP53 protein CTD PMID:34036453 3-Nitrobenzanthrone increases mutagenesis ISO RGD:70502 6480464 3-nitrobenzanthrone results in increased mutagenesis of TP53 gene CTD PMID:18765419 3-Nitrobenzanthrone increases expression EXP 6480464 3-nitrobenzanthrone results in increased expression of TRP53 protein CTD PMID:25230394 3-Nitrofluoranthene multiple interactions EXP 6480464 3-nitrofluoranthene results in increased phosphorylation of and affects the localization of TRP53 protein CTD PMID:19041363 3-phenylprop-2-enal decreases expression ISO RGD:70502 6480464 cinnamaldehyde results in decreased expression of TP53 mRNA CTD PMID:17178418 4'-epidoxorubicin multiple interactions ISO RGD:70502 6480464 3' more ... CTD PMID:22914566 , PMID:26335193 4'-epidoxorubicin increases expression ISO RGD:70502 6480464 Epirubicin results in increased expression of TP53 mRNA CTD PMID:22914566 , PMID:26335193 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions ISO RGD:70502 6480464 4 more ... CTD PMID:10951577 4,4'-sulfonyldiphenol increases expression ISO RGD:70502 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of TP53 mRNA, bis(4-hydroxyphenyl)sulfone results in increased expression of TP53 protein CTD PMID:36565802 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of TRP53 mRNA CTD PMID:32742594 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:70502 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TP53 protein] more ... CTD PMID:18805435 , PMID:19931552 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:70502 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TP53 protein CTD PMID:19931552 more ... 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of TRP53 mRNA CTD PMID:21167638 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases ADP-ribosylation ISO RGD:70502 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased ADP-ribosylation of TP53 protein CTD PMID:20421341 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases phosphorylation ISO RGD:70502 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of TP53 protein CTD PMID:20421341 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO RGD:70502 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TP53 protein CTD PMID:18805435 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one affects localization ISO RGD:70502 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone affects the localization of TP53 protein CTD PMID:19931552 , PMID:20421341 4-amino-2,6-dinitrotoluene affects expression ISO RGD:3889 6480464 4-amino-2, 6-dinitrotoluene affects the expression of TP53 mRNA CTD PMID:21346803 4-Aminobenzamide multiple interactions EXP 6480464 4-aminobenzamide promotes the reaction [Acetaminophen results in decreased expression of TRP53 protein] CTD PMID:11461765 4-aminofolic acid affects activity ISO RGD:70502 6480464 Aminopterin affects the activity of TP53 protein, Aminopterin metabolite affects the activity of TP53 protein CTD PMID:35435491 4-chloroaniline affects expression ISO RGD:70502 6480464 4-chloroaniline affects the expression of TP53 mRNA CTD PMID:27825931 4-hydroperoxycyclophosphamide multiple interactions ISO RGD:70502 6480464 Acetylcysteine inhibits the reaction [perfosfamide results in increased expression of TP53] CTD PMID:18034189 4-hydroperoxycyclophosphamide multiple interactions EXP 6480464 perfosfamide results in increased expression of and results in increased phosphorylation of and results in increased activity of TRP53 protein CTD PMID:17068108 4-hydroperoxycyclophosphamide increases expression ISO RGD:70502 6480464 perfosfamide results in increased expression of TP53 CTD PMID:18034189 4-hydroxy-TEMPO increases expression ISO RGD:70502 6480464 tempol results in increased expression of TP53 protein CTD PMID:15601469 4-hydroxynon-2-enal increases mutagenesis ISO RGD:70502 6480464 4-hydroxy-2-nonenal results in increased mutagenesis of TP53 gene CTD PMID:11050162 4-hydroxynon-2-enal affects abundance EXP 6480464 TRP53 protein affects the abundance of 4-hydroxy-2-nonenal CTD PMID:22229939 4-hydroxynon-2-enal increases expression ISO RGD:70502 6480464 4-hydroxy-2-nonenal results in increased expression of TP53 mRNA, 4-hydroxy-2-nonenal results in increased expression of TP53 protein CTD PMID:15607904 4-hydroxyphenyl retinamide affects expression ISO RGD:70502 6480464 Fenretinide affects the expression of TP53 CTD PMID:16720286 4-hydroxyphenyl retinamide increases expression ISO RGD:70502 6480464 Fenretinide results in increased expression of TP53 mRNA, Fenretinide results in increased expression of TP53 protein CTD PMID:16540676 more ... 4-hydroxyphenyl retinamide decreases expression ISO RGD:70502 6480464 Fenretinide results in decreased expression of TP53 mRNA CTD PMID:7811993 4-methylumbelliferone affects activity ISO RGD:70502 6480464 Hymecromone affects the activity of TP53 protein, Hymecromone metabolite affects the activity of TP53 protein CTD PMID:35435491 4-Nerolidylcatechol increases expression ISO RGD:70502 6480464 4-nerolidylcatechol results in increased expression of TP53 protein CTD PMID:22372875 , PMID:32334110 4-nitrophenol affects glucuronidation ISO RGD:70502 6480464 TP53 protein affects the glucuronidation of 4-nitrophenol CTD PMID:11695553 4-nitroquinoline N-oxide affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to 4-Nitroquinoline-1-oxide CTD PMID:16543248 4-nitroquinoline N-oxide increases expression ISO RGD:70502 6480464 4-Nitroquinoline-1-oxide results in increased expression of TP53 protein CTD PMID:32087850 4-nitroquinoline N-oxide decreases expression ISO RGD:3889 6480464 4-Nitroquinoline-1-oxide results in decreased expression of TP53 protein CTD PMID:20599846 4-nonylphenol increases expression ISO RGD:3889 6480464 4-nonylphenol results in increased expression of TP53 mRNA, 4-nonylphenol results in increased expression of TP53 protein CTD PMID:27087316 , PMID:27109770 4-nonylphenol increases phosphorylation ISO RGD:70502 6480464 4-nonylphenol results in increased phosphorylation of TP53 protein CTD PMID:32466334 4-phenylbutyric acid multiple interactions ISO RGD:3889 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of TP53 protein] CTD PMID:30980806 4-tert-Octylphenol increases expression ISO RGD:3889 6480464 4-tert-octylphenol results in increased expression of TP53 mRNA CTD PMID:17011747 4-tert-Octylphenol increases phosphorylation ISO RGD:70502 6480464 4-tert-octylphenol results in increased phosphorylation of TP53 protein CTD PMID:32466334 5'-S-methyl-5'-thioadenosine increases expression ISO RGD:70502 6480464 5'-methylthioadenosine results in increased expression of TP53 protein CTD PMID:31712395 5,6,7,8-tetrahydrobiopterin multiple interactions ISO RGD:70502 6480464 sapropterin inhibits the reaction [Methotrexate results in increased expression of TP53 protein] CTD PMID:22183962 5-(2-chloroethyl)-4-methylthiazole multiple interactions ISO RGD:3889 6480464 Chlormethiazole inhibits the reaction [Acetaminophen results in increased degradation of TP53 protein] CTD PMID:16330492 5-aminolevulinic acid increases expression ISO RGD:70502 6480464 Aminolevulinic Acid analog results in increased expression of TP53 CTD PMID:17311614 5-aza-2'-deoxycytidine multiple interactions ISO RGD:70502 6480464 [Decitabine affects the methylation of BAX gene] affects the reaction [TP53 protein results in increased expression of BAX mRNA] more ... CTD PMID:14722112 more ... 5-aza-2'-deoxycytidine increases acetylation ISO RGD:70502 6480464 Decitabine results in increased acetylation of TP53 protein CTD PMID:17977830 5-aza-2'-deoxycytidine affects localization ISO RGD:70502 6480464 Decitabine affects the localization of TP53 protein, Decitabine affects the localization of TP53 protein modified form CTD PMID:17991895 , PMID:19037090 5-aza-2'-deoxycytidine increases phosphorylation ISO RGD:70502 6480464 Decitabine results in increased phosphorylation of TP53 protein CTD PMID:18636160 , PMID:19732952 5-aza-2'-deoxycytidine increases expression ISO RGD:70502 6480464 Decitabine results in increased expression of TP53 mRNA, Decitabine results in increased expression of TP53 protein CTD PMID:15753979 more ... 5-aza-2'-deoxycytidine increases expression ISO RGD:3889 6480464 Decitabine results in increased expression of TP53 mRNA CTD PMID:21449042 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of TRP53 mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine increases activity ISO RGD:70502 6480464 Decitabine results in increased activity of TP53 protein CTD PMID:30818834 5-aza-2'-deoxycytidine decreases ubiquitination ISO RGD:70502 6480464 Decitabine results in decreased ubiquitination of TP53 protein CTD PMID:17977830 5-aza-2'-deoxycytidine decreases methylation ISO RGD:70502 6480464 Decitabine results in decreased methylation of TP53 promoter CTD PMID:19037090 5-aza-2'-deoxycytidine decreases methylation ISO RGD:3889 6480464 Decitabine results in decreased methylation of TP53 promoter CTD PMID:21449042 5-azacytidine affects activity ISO RGD:70502 6480464 Azacitidine affects the activity of TP53 protein CTD PMID:35435491 5-chloro-7-iodoquinolin-8-ol multiple interactions ISO RGD:70502 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Clioquinol results in increased phosphorylation of TP53 protein] CTD PMID:22627294 5-chloro-7-iodoquinolin-8-ol increases phosphorylation ISO RGD:70502 6480464 Clioquinol results in increased phosphorylation of TP53 protein CTD PMID:22627294 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of TRP53 protein CTD PMID:16949053 more ... 5-fluorouracil affects activity ISO RGD:70502 6480464 Fluorouracil affects the activity of TP53 protein CTD PMID:35435491 5-fluorouracil multiple interactions EXP 6480464 Fluorouracil promotes the reaction [Luteolin results in increased expression of TRP53 protein], Luteolin promotes the reaction [Fluorouracil results in increased expression of TRP53 protein] CTD PMID:31288002 5-fluorouracil increases acetylation ISO RGD:70502 6480464 Fluorouracil results in increased acetylation of TP53 protein mutant form CTD PMID:27129209 5-fluorouracil increases phosphorylation ISO RGD:70502 6480464 Fluorouracil results in increased phosphorylation of TP53 protein CTD PMID:15489892 more ... 5-fluorouracil affects phosphorylation ISO RGD:70502 6480464 Fluorouracil affects the phosphorylation of TP53 protein CTD PMID:23941782 5-fluorouracil decreases response to substance ISO RGD:70502 6480464 TP53 promoter mutant form results in decreased susceptibility to Fluorouracil CTD PMID:22445862 5-fluorouracil decreases expression ISO RGD:70502 6480464 Fluorouracil results in decreased expression of TP53 mRNA CTD PMID:16709241 , PMID:18930000 5-fluorouracil increases response to substance EXP 6480464 TRP53 results in increased susceptibility to Fluorouracil CTD PMID:9050858 5-fluorouracil increases activity EXP 6480464 Fluorouracil results in increased activity of TRP53 protein CTD PMID:16949053 5-fluorouracil increases expression ISO RGD:3889 6480464 Fluorouracil results in increased expression of TP53 protein, Fluorouracil results in increased expression of TRP53 protein CTD PMID:15459018 , PMID:35101590 5-fluorouracil multiple interactions ISO RGD:3889 6480464 ferrostatin-1 inhibits the reaction [Fluorouracil results in increased expression of TRP53 protein] more ... CTD PMID:15459018 more ... 5-fluorouracil increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to Fluorouracil, TP53 results in increased susceptibility to Fluorouracil CTD PMID:14646558 more ... 5-fluorouracil affects response to substance ISO RGD:70502 6480464 TP53 gene polymorphism affects the susceptibility to Fluorouracil, TP53 protein affects the susceptibility to Fluorouracil CTD PMID:14665630 more ... 5-fluorouracil increases expression ISO RGD:70502 6480464 Fluorouracil results in increased expression of TP53 more ... CTD PMID:11750847 more ... 5-fluorouracil increases activity ISO RGD:70502 6480464 Fluorouracil results in increased activity of TP53 protein CTD PMID:18779317 , PMID:19010883 5-fluorouracil decreases degradation ISO RGD:70502 6480464 Fluorouracil results in decreased degradation of TP53 protein CTD PMID:15625077 5-fluorouracil multiple interactions ISO RGD:70502 6480464 [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of TP53 mRNA more ... CTD PMID:14665630 more ... 5-methoxypsoralen multiple interactions ISO RGD:70502 6480464 5-Methoxypsoralen results in increased expression of and results in increased phosphorylation of TP53 protein CTD PMID:30576070 5-methoxypsoralen affects activity ISO RGD:70502 6480464 5-Methoxypsoralen metabolite affects the activity of TP53 protein CTD PMID:35435491 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide increases acetylation ISO RGD:70502 6480464 6-chloro-2 more ... CTD PMID:24726431 , PMID:29545174 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:3889 6480464 [6-chloro-2 more ... CTD PMID:35307491 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide increases acetylation ISO RGD:3889 6480464 6-chloro-2 more ... CTD PMID:35307491 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide increases acetylation EXP 6480464 6-chloro-2 more ... CTD PMID:21593185 , PMID:32017914 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:21593185 more ... 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:70502 6480464 Camptothecin inhibits the reaction [6-chloro-2 more ... CTD PMID:24726431 6-O-methylguanine multiple interactions ISO RGD:70502 6480464 [O(6)-benzylguanine results in increased susceptibility to O-(6)-methylguanine] which results in increased expression of TP53 mRNA mutant form CTD PMID:29666243 6-oxocampestanol increases expression ISO RGD:70502 6480464 6-oxocampestanol results in increased expression of TP53 protein CTD PMID:32001316 6-propyl-2-thiouracil increases expression ISO RGD:3889 6480464 Propylthiouracil results in increased expression of TP53 mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:20043298 more ... 7,12-dimethyltetraphene increases phosphorylation EXP 6480464 9 more ... CTD PMID:35908932 7,12-dimethyltetraphene multiple interactions ISO RGD:3889 6480464 [Ruthenium binds to Phloretin] inhibits the reaction [9 more ... CTD PMID:30101532 , PMID:34896434 7,12-dimethyltetraphene increases expression ISO RGD:3889 6480464 9 more ... CTD PMID:24269759 7,12-dimethyltetraphene decreases expression ISO RGD:3889 6480464 9 more ... CTD PMID:24269759 more ... 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:12734332 more ... 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:33347706 7,12-dimethyltetraphene increases activity ISO RGD:70502 6480464 9 more ... CTD PMID:20655369 7,12-dimethyltetraphene multiple interactions ISO RGD:70502 6480464 2 more ... CTD PMID:22009531 , PMID:32553695 7,8-Diacetoxy-4-methylcoumarin increases expression ISO RGD:70502 6480464 7, 8-diacetoxy-4-methylcoumarin results in increased expression of TP53 protein CTD PMID:19061872 7,9-dihydro-1H-purine-2,6,8(3H)-trione increases phosphorylation EXP 6480464 Uric Acid results in increased phosphorylation of TRP53 protein CTD PMID:23619996 7-amino-4-hydroxy-2-naphthalenesulfonic acid affects activity ISO RGD:70502 6480464 7-amino-4-hydroxy-2-naphthalenesulfonic acid affects the activity of TP53 protein, 7-amino-4-hydroxy-2-naphthalenesulfonic acid metabolite affects the activity of TP53 protein CTD PMID:35435491 7-ketocholesterol multiple interactions ISO RGD:3889 6480464 Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of TP53 protein] more ... CTD PMID:25845326 7-ketocholesterol increases expression ISO RGD:3889 6480464 7-ketocholesterol results in increased expression of TP53 protein CTD PMID:25845326 7-NITROINDAZOLE multiple interactions ISO RGD:3889 6480464 [7-nitroindazole results in decreased chemical synthesis of Nitric Oxide] inhibits the reaction [Paraquat results in increased phosphorylation of TP53 protein] CTD PMID:20478973 8-Br-cAMP increases expression ISO RGD:70502 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53, 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53 protein CTD PMID:10642304 , PMID:11802967 8-bromo-3',5'-cyclic GMP increases expression ISO RGD:3889 6480464 8-bromocyclic GMP results in increased expression of TP53 protein CTD PMID:9888876 9,10-phenanthroquinone affects localization ISO RGD:70502 6480464 9, 10-phenanthrenequinone affects the localization of TP53 protein CTD PMID:29108775 9,11,13-octadecatrienoic acid increases expression ISO RGD:70502 6480464 eleostearic acid results in increased expression of TP53 protein CTD PMID:15961301 9-aminoacridine multiple interactions ISO RGD:70502 6480464 Aminacrine results in increased stability of and results in increased activity of TP53 protein CTD PMID:16177561 9-aminoacridine affects activity ISO RGD:70502 6480464 Aminacrine analog affects the activity of TP53 protein CTD PMID:35435491 [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID affects activity ISO RGD:70502 6480464 3 more ... CTD PMID:35435491 ABT-737 multiple interactions ISO RGD:70502 6480464 [ABT-737 co-treated with hydroquinone] results in increased expression of TRP53 protein CTD PMID:28843007 acetamide increases expression ISO RGD:3889 6480464 acetamide results in increased expression of TP53 mRNA CTD PMID:31881176 acetamiprid increases expression EXP 6480464 acetamiprid results in increased expression of TP53 protein CTD PMID:36457797 acetic acid decreases expression ISO RGD:70502 6480464 Acetic Acid results in decreased expression of TP53 mRNA CTD PMID:35750087 acetylsalicylic acid increases acetylation ISO RGD:70502 6480464 Aspirin results in increased acetylation of TP53 protein CTD PMID:19212664 acetylsalicylic acid multiple interactions ISO RGD:70502 6480464 Aspirin inhibits the reaction [sodium bichromate results in increased expression of TP53 protein] CTD PMID:10942736 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of TRP53 protein CTD PMID:16880202 acetylsalicylic acid increases expression ISO RGD:70502 6480464 Aspirin results in increased expression of TP53 protein CTD PMID:12535653 aconitine increases expression ISO RGD:3889 6480464 Aconitine results in increased expression of TP53 protein CTD PMID:24840785 acridine orange multiple interactions ISO RGD:70502 6480464 Acridine Orange results in increased stability of and results in increased activity of TP53 protein CTD PMID:16177561 acridine orange free base multiple interactions ISO RGD:70502 6480464 Acridine Orange results in increased stability of and results in increased activity of TP53 protein CTD PMID:16177561 acrolein affects metabolic processing ISO RGD:70502 6480464 Acrolein affects the metabolism of TP53 protein CTD PMID:12807757 acrolein increases expression ISO RGD:70502 6480464 Acrolein results in increased expression of TP53 protein CTD PMID:34958888 acrolein affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to Acrolein CTD PMID:29964147 acrolein multiple interactions ISO RGD:3889 6480464 [ferric oxide analog co-treated with Acrolein] results in increased expression of TP53 protein CTD PMID:24847785 acrolein increases mutagenesis ISO RGD:70502 6480464 Acrolein results in increased mutagenesis of TP53 gene CTD PMID:17030796 acrolein decreases activity ISO RGD:70502 6480464 Acrolein results in decreased activity of TP53 protein CTD PMID:12807757 , PMID:16753831 acrolein affects binding ISO RGD:70502 6480464 Acrolein binds to TP53 gene CTD PMID:17030796 acrolein multiple interactions ISO RGD:70502 6480464 [TP53 protein affects the susceptibility to Acrolein] which affects the localization of CCNB1 protein more ... CTD PMID:12807757 , PMID:29964147 acrylamide increases expression ISO RGD:3889 6480464 Acrylamide results in increased expression of TP53 mRNA CTD PMID:36598108 acrylamide multiple interactions ISO RGD:3889 6480464 naringin inhibits the reaction [Acrylamide results in increased expression of TP53 mRNA] CTD PMID:36598108 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of TRP53 mRNA, Acrylamide results in increased expression of TRP53 protein CTD PMID:25531190 more ... acrylamide multiple interactions EXP 6480464 ATF3 protein promotes the reaction [Acrylamide results in increased expression of TRP53 protein] CTD PMID:25531190 acrylamide multiple interactions ISO RGD:70502 6480464 Acrylamide results in increased phosphorylation of and results in increased expression of TP53 protein CTD PMID:19426797 acrylamide increases expression ISO RGD:70502 6480464 Acrylamide results in increased expression of TP53 protein modified form CTD PMID:20734998 acrylamide increases mutagenesis ISO RGD:70502 6480464 Acrylamide results in increased mutagenesis of TP53 gene CTD PMID:15240786 acrylonitrile increases expression ISO RGD:70502 6480464 Acrylonitrile results in increased expression of TP53 protein CTD PMID:33132245 actinomycin D multiple interactions ISO RGD:70502 6480464 [TNF protein co-treated with Dactinomycin] results in decreased expression of TP53 protein more ... CTD PMID:10531375 more ... actinomycin D multiple interactions ISO RGD:70502 150537096 Actinomycin D inhibits the reaction [Sunitinib increases expression of TP53 mRNA and protein in breast epithelium] RGD actinomycin D increases activity ISO RGD:70502 6480464 Dactinomycin results in increased activity of TP53 protein CTD PMID:12869419 , PMID:20655369 actinomycin D increases expression ISO RGD:70502 6480464 Dactinomycin results in increased expression of TP53 protein, Dactinomycin results in increased expression of TP53 protein modified form CTD PMID:12927789 , PMID:17581298 adefovir pivoxil affects activity ISO RGD:70502 6480464 adefovir dipivoxil affects the activity of TP53 protein CTD PMID:25596134 , PMID:35435491 aflatoxin B1 affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to Aflatoxin B1 CTD PMID:24380836 aflatoxin B1 affects activity ISO RGD:70502 6480464 Aflatoxin B1 metabolite affects the activity of TP53 protein CTD PMID:35435491 aflatoxin B1 increases phosphorylation ISO RGD:70502 6480464 Aflatoxin B1 results in increased phosphorylation of TP53 protein CTD PMID:32106047 , PMID:33984424 aflatoxin B1 increases methylation ISO RGD:70502 6480464 Aflatoxin B1 results in increased methylation of TP53 gene CTD PMID:28458013 aflatoxin B1 decreases expression ISO RGD:70502 6480464 Aflatoxin B1 results in decreased expression of TP53 mRNA CTD PMID:28943387 aflatoxin B1 multiple interactions ISO RGD:3889 6480464 Acetylcysteine inhibits the reaction [Aflatoxin B1 promotes the reaction [fumonisin B1 results in increased expression of TP53 protein]] more ... CTD PMID:28181396 aflatoxin B1 affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to Aflatoxin B1 CTD PMID:28882572 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TRP53 mRNA, Aflatoxin B1 results in increased expression of TRP53 protein CTD PMID:28789997 more ... aflatoxin B1 increases expression ISO RGD:70502 6480464 Aflatoxin B1 results in increased expression of TP53 mRNA, Aflatoxin B1 results in increased expression of TP53 protein CTD PMID:22100608 more ... aflatoxin B1 multiple interactions ISO RGD:70502 6480464 [Zearalenone co-treated with Aflatoxin B1] promotes the reaction [deoxynivalenol results in increased expression of TP53 mRNA] more ... CTD PMID:20655369 more ... aflatoxin B1 increases activity ISO RGD:70502 6480464 Aflatoxin B1 results in increased activity of TP53 protein CTD PMID:20655369 aflatoxin B1 increases mutagenesis ISO RGD:70502 6480464 Aflatoxin B1 results in increased mutagenesis of TP53 gene CTD PMID:12619106 , PMID:15946497 aflatoxin B1 increases expression ISO RGD:3889 6480464 Aflatoxin B1 results in increased expression of TP53 mRNA, Aflatoxin B1 results in increased expression of TP53 protein CTD PMID:28181396 more ... aflatoxin B1 affects expression ISO RGD:70502 6480464 Aflatoxin B1 affects the expression of TP53 protein CTD PMID:20106945 Aflatoxin G1 increases expression ISO RGD:70502 6480464 aflatoxin G1 results in increased expression of TP53 protein modified form CTD PMID:23907605 Aflatoxin G1 increases activity ISO RGD:70502 6480464 aflatoxin G1 results in increased activity of TP53 protein CTD PMID:23907605 Aflatoxin G1 multiple interactions ISO RGD:70502 6480464 Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of TP53 protein modified form], Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of TP53 protein modified form] CTD PMID:23907605 AICA ribonucleotide multiple interactions ISO RGD:70502 6480464 [Resveratrol co-treated with AICA ribonucleotide] inhibits the reaction [Glucose results in increased expression of TP53 protein] more ... CTD PMID:26188290 , PMID:33070465 AICA ribonucleotide increases phosphorylation ISO RGD:70502 6480464 AICA ribonucleotide results in increased phosphorylation of TP53 protein CTD PMID:33070465 alantolactone increases expression ISO RGD:70502 6480464 alantolactone results in increased expression of TP53 protein CTD PMID:22721982 albendazole affects activity ISO RGD:70502 6480464 Albendazole affects the activity of TP53 protein CTD PMID:35435491 albendazole S-oxide affects activity ISO RGD:70502 6480464 albendazole sulfoxide affects the activity of TP53 protein CTD PMID:35435491 albuterol increases expression ISO RGD:70502 6480464 Albuterol results in increased expression of TP53 CTD PMID:11802967 aldehydo-D-glucose multiple interactions ISO RGD:70502 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein]] more ... CTD PMID:20068143 more ... aldehydo-D-glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein more ... CTD PMID:28675767 aldehydo-D-glucose increases expression ISO RGD:70502 6480464 Glucose results in increased expression of TP53 mRNA, Glucose results in increased expression of TP53 protein CTD PMID:26188290 more ... aldehydo-D-glucose multiple interactions ISO RGD:3889 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] more ... CTD PMID:23451161 , PMID:25997894 aldehydo-D-glucose increases acetylation ISO RGD:70502 6480464 Glucose results in increased acetylation of TP53 protein CTD PMID:20068143 aldehydo-D-glucose affects localization ISO RGD:70502 6480464 Glucose affects the localization of TP53 protein CTD PMID:24218232 all-cis-docosa-7,10,13,16-tetraenoic acid multiple interactions EXP 6480464 [TP53 protein mutant form results in increased susceptibility to Niclosamide] which results in increased abundance of adrenic acid CTD PMID:30258081 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of TRP53 mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of TRP53 protein CTD PMID:33823233 all-trans-retinoic acid decreases expression ISO RGD:3889 6480464 Tretinoin results in decreased expression of TP53 protein CTD PMID:17962954 all-trans-retinoic acid increases expression ISO RGD:70502 6480464 Tretinoin results in increased expression of TP53 mRNA, Tretinoin results in increased expression of TP53 protein CTD PMID:15254726 more ... all-trans-retinoic acid increases activity ISO RGD:70502 6480464 Tretinoin results in increased activity of TP53 protein CTD PMID:15674351 all-trans-retinoic acid decreases expression ISO RGD:70502 6480464 Tretinoin results in decreased expression of TP53 mRNA, Tretinoin results in decreased expression of TP53 protein CTD PMID:16461808 , PMID:34742744 all-trans-retinoic acid multiple interactions ISO RGD:70502 6480464 [Tretinoin co-treated with zoledronic acid] results in decreased expression of TP53 protein more ... CTD PMID:16740359 more ... all-trans-retinoic acid affects expression ISO RGD:70502 6480464 Tretinoin affects the expression of TP53 CTD PMID:16720286 allethrin increases expression ISO RGD:3889 6480464 Allethrins results in increased expression of TP53 mRNA CTD PMID:25072698 allethrin decreases expression ISO RGD:3889 6480464 Allethrins results in decreased expression of TP53 mRNA CTD PMID:23595975 allethrin affects expression ISO RGD:3889 6480464 Allethrins affects the expression of TP53 protein CTD PMID:22356257 alliin multiple interactions ISO RGD:70502 6480464 alliin promotes the reaction [FGF2 protein results in increased expression of TP53 protein] CTD PMID:16351512 allose increases expression ISO RGD:70502 6480464 allose results in increased expression of TP53 mRNA, allose results in increased expression of TP53 protein CTD PMID:18930000 allose multiple interactions ISO RGD:70502 6480464 Fluorouracil promotes the reaction [allose results in increased expression of TP53 protein] CTD PMID:18930000 Aloe emodin increases expression ISO RGD:70502 6480464 aloe emodin results in increased expression of TP53 protein CTD PMID:19928967 alpha-D-galactose increases expression ISO RGD:70502 6480464 Galactose results in increased expression of TP53 protein CTD PMID:23036742 , PMID:29426000 alpha-D-galactose multiple interactions ISO RGD:3889 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] CTD PMID:25997894 alpha-D-galactose multiple interactions ISO RGD:70502 6480464 Phycocyanin inhibits the reaction [Galactose results in increased expression of TP53 protein] CTD PMID:23036742 alpha-hexachlorocyclohexane increases expression ISO RGD:3889 6480464 alpha-hexachlorocyclohexane results in increased expression of TP53 mRNA CTD PMID:16940010 alpha-hexachlorocyclohexane affects expression ISO RGD:3889 6480464 alpha-hexachlorocyclohexane affects the expression of TRP53 mRNA CTD PMID:16940010 alpha-hexachlorocyclohexane decreases expression ISO RGD:3889 6480464 alpha-hexachlorocyclohexane results in decreased expression of TP53 mRNA CTD PMID:16940010 alpha-mangostin increases expression ISO RGD:70502 6480464 mangostin results in increased expression of TP53 protein CTD PMID:24480042 alpha-mangostin multiple interactions ISO RGD:70502 6480464 mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of TP53 mRNA] CTD PMID:26357513 alpha-naphthoflavone multiple interactions ISO RGD:3889 6480464 alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [leptomycin B results in increased expression of TP53 protein]] CTD PMID:15459018 alpha-naphthoflavone multiple interactions ISO RGD:70502 6480464 alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9 more ... CTD PMID:32553695 alpha-naphthoflavone increases expression ISO RGD:70502 6480464 alpha-naphthoflavone results in increased expression of TP53 protein CTD PMID:29274324 alpha-naphthoflavone multiple interactions EXP 6480464 alpha-naphthoflavone inhibits the reaction [9 more ... CTD PMID:35908932 , PMID:9006915 alpha-phellandrene affects localization ISO RGD:70502 6480464 alpha phellandrene affects the localization of TP53 protein CTD PMID:25649747 alpha-phellandrene decreases expression EXP 6480464 alpha phellandrene results in decreased expression of TRP53 protein CTD PMID:24861204 alpha-phellandrene increases phosphorylation EXP 6480464 alpha phellandrene results in increased phosphorylation of TRP53 protein CTD PMID:24861204 alpha-phellandrene increases expression EXP 6480464 alpha phellandrene results in increased expression of TRP53 protein modified form CTD PMID:24861204 alsterpaullone multiple interactions ISO RGD:70502 6480464 alsterpaullone results in decreased degradation of and results in increased expression of TP53 protein CTD PMID:16055726 alsterpaullone affects localization ISO RGD:70502 6480464 alsterpaullone affects the localization of TP53 protein CTD PMID:16055726 alternariol increases expression ISO RGD:70502 6480464 alternariol results in increased expression of TP53 protein CTD PMID:22542754 aluminium oxide increases expression ISO RGD:70502 6480464 Aluminum Oxide analog results in increased expression of TP53 mRNA CTD PMID:23132795 alvocidib decreases expression ISO RGD:70502 6480464 alvocidib results in decreased expression of TP53 protein CTD PMID:9808574 alvocidib multiple interactions ISO RGD:70502 6480464 [docetaxel co-treated with alvocidib] results in increased expression of TP53 protein CTD PMID:15297405 alvocidib increases expression ISO RGD:70502 6480464 [alvocidib results in increased expression of TP53 protein] which results in increased expression of CDKN1B protein, alvocidib results in increased expression of TP53 protein CTD PMID:10537362 more ... amifostine multiple interactions ISO RGD:70502 6480464 [Amifostine co-treated with TP53] results in increased expression of MYC mRNA more ... CTD PMID:14555708 , PMID:16628227 amifostine increases expression ISO RGD:70502 6480464 Amifostine results in increased expression of TP53 protein CTD PMID:12618886 amifostine affects response to substance ISO RGD:70502 6480464 TP53 affects the susceptibility to Amifostine CTD PMID:12618886 amifostine increases activity ISO RGD:70502 6480464 Amifostine results in increased activity of TP53 protein CTD PMID:16628227 amiodarone decreases expression ISO RGD:70502 6480464 Amiodarone results in decreased expression of TP53 mRNA CTD PMID:35641671 ammonium chloride increases expression ISO RGD:3889 6480464 Ammonium Chloride results in increased expression of TP53 protein CTD PMID:16483693 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of TRP53 mRNA CTD PMID:31310755 ammonium chloride multiple interactions ISO RGD:70502 6480464 Ammonium Chloride affects the expression of and affects the phosphorylation of TP53 protein, NR1I2 protein affects the reaction [Ammonium Chloride affects the expression of and affects the phosphorylation of TP53 protein] CTD PMID:29908302 ammonium chloride affects expression ISO RGD:3889 6480464 Ammonium Chloride affects the expression of TP53 mRNA CTD PMID:16483693 amodiaquine increases activity ISO RGD:70502 6480464 Amodiaquine results in increased activity of TP53 protein CTD PMID:12082016 amodiaquine affects expression ISO RGD:70502 6480464 Amodiaquine affects the expression of TP53 protein CTD PMID:24113242 amosite asbestos affects localization ISO RGD:70502 6480464 Asbestos, Amosite affects the localization of TP53 protein CTD PMID:16357363 amosite asbestos multiple interactions ISO RGD:3889 6480464 Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 protein] CTD PMID:16357363 amosite asbestos increases expression ISO RGD:3889 6480464 Asbestos, Amosite results in increased expression of TP53 protein CTD PMID:16357363 amosite asbestos increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to Asbestos, Amosite CTD PMID:16357363 amosite asbestos multiple interactions ISO RGD:70502 6480464 Deferoxamine inhibits the reaction [Asbestos more ... CTD PMID:16357363 amosite asbestos increases expression ISO RGD:70502 6480464 Asbestos more ... CTD PMID:16357363 amphetamine decreases expression ISO RGD:3889 6480464 Amphetamine results in decreased expression of TP53 mRNA CTD PMID:30779732 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of TRP53 mRNA, Amphetamine results in increased expression of TRP53 protein CTD PMID:15731293 amphibole asbestos multiple interactions ISO RGD:70502 6480464 Asbestos, Amphibole results in increased phosphorylation of and results in increased stability of TP53 protein CTD PMID:20705543 amphibole asbestos affects expression ISO RGD:70502 6480464 Asbestos, Amphibole affects the expression of TP53 protein CTD PMID:20855422 amsacrine increases activity ISO RGD:70502 6480464 Amsacrine analog results in increased activity of TP53 protein CTD PMID:12082016 amsacrine increases glutathionylation ISO RGD:70502 6480464 Amsacrine results in increased glutathionylation of TP53 protein CTD PMID:17555331 amsacrine multiple interactions ISO RGD:70502 6480464 Amsacrine results in increased stability of and results in increased activity of TP53 protein CTD PMID:16177561 amsacrine increases expression ISO RGD:70502 6480464 Amsacrine results in increased expression of TP53 protein CTD PMID:11774253 andrographolide multiple interactions ISO RGD:70502 6480464 andrographolide results in increased expression of and results in increased phosphorylation of TP53 protein, Fluorouracil promotes the reaction [andrographolide results in increased expression of TP53] CTD PMID:18619950 , PMID:19097688 andrographolide increases expression ISO RGD:70502 6480464 andrographolide results in increased expression of TP53 CTD PMID:19097688 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone promotes the reaction [TRP53 gene mutant form results in decreased susceptibility to sodium arsenite] CTD PMID:16166651 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:3889 6480464 pyrazolanthrone inhibits the reaction [Colistin results in increased expression of TP53 protein] CTD PMID:28842171 anthra[1,9-cd]pyrazol-6(2H)-one increases phosphorylation ISO RGD:70502 6480464 pyrazolanthrone results in increased phosphorylation of TP53 protein CTD PMID:25305377 anthra[1,9-cd]pyrazol-6(2H)-one increases expression ISO RGD:70502 6480464 pyrazolanthrone results in increased expression of TP53 protein, pyrazolanthrone results in increased expression of TP53 protein modified form CTD PMID:15034932 more ... anthra[1,9-cd]pyrazol-6(2H)-one decreases expression ISO RGD:70502 6480464 pyrazolanthrone results in decreased expression of TP53 protein CTD PMID:16450001 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:70502 6480464 [sodium arsenite co-treated with pyrazolanthrone] promotes the reaction [HSPA9 protein binds to TP53 protein modified form] more ... CTD PMID:15034932 more ... anthra[1,9-cd]pyrazol-6(2H)-one increases phosphorylation ISO RGD:3889 6480464 pyrazolanthrone results in increased phosphorylation of TP53 protein CTD PMID:16046226 antimycin A increases response to substance ISO RGD:70502 6480464 TRP53 protein results in increased susceptibility to Antimycin A CTD PMID:24040102 antimycin A increases acetylation EXP 6480464 Antimycin A results in increased acetylation of TRP53 protein CTD PMID:24040102 antimycin A multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:24040102 aphidicolin multiple interactions EXP 6480464 [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased activity of ATM protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein], [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein] CTD PMID:22003191 apigenin multiple interactions ISO RGD:70502 6480464 TP53 protein affects the reaction [Apigenin results in increased expression of CDKN1A protein] CTD PMID:11790449 apigenin affects activity ISO RGD:70502 6480464 Apigenin affects the activity of TP53 protein CTD PMID:35435491 apigenin increases expression ISO RGD:70502 6480464 Apigenin results in increased expression of TP53 protein CTD PMID:16023288 apocynin multiple interactions ISO RGD:3889 6480464 acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein] CTD PMID:22431579 arachidonic acid multiple interactions EXP 6480464 [TP53 protein mutant form results in increased susceptibility to Niclosamide] which results in increased abundance of Arachidonic Acid CTD PMID:30258081 arachidonic acid multiple interactions ISO RGD:70502 6480464 [TP53 protein results in increased expression of ALOX12B mRNA] which results in increased metabolism of Arachidonic Acid, [TP53 protein results in increased expression of ALOX5 mRNA] which results in increased metabolism of Arachidonic Acid CTD PMID:30258081 arachidonyl-2'-chloroethylamide multiple interactions EXP 6480464 arachidonyl-2-chloroethylamide inhibits the reaction [Cisplatin results in increased phosphorylation of TRP53 protein] CTD PMID:31256211 arecoline increases expression ISO RGD:70502 6480464 Arecoline results in increased expression of TP53 protein CTD PMID:22108589 arecoline multiple interactions ISO RGD:70502 6480464 [[Arecoline results in decreased expression of CDC25C] co-treated with [Arecoline results in increased expression of TP53]] results in decreased activity of CDK1 protein CTD PMID:22108589 Arg-Gly-Asp multiple interactions ISO RGD:70502 6480464 arginyl-glycyl-aspartic acid inhibits the reaction [Resveratrol results in increased phosphorylation of TP53 protein] CTD PMID:16790523 aristolochic acid A increases expression ISO RGD:70502 6480464 aristolochic acid I results in increased expression of TP53 mRNA CTD PMID:33212167 aristolochic acid A multiple interactions ISO RGD:70502 6480464 aristolochic acid I results in increased expression of and results in increased phosphorylation of TP53 protein CTD PMID:33938965 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of TRP53 protein CTD PMID:31602497 aristolochic acid A multiple interactions EXP 6480464 TRP53 protein affects the reaction [aristolochic acid I results in increased expression of H2AX protein], TRP53 protein affects the reaction [aristolochic acid I results in increased expression of NQO1 protein] CTD PMID:31602497 aristolochic acid A affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to aristolochic acid I CTD PMID:31602497 aristolochic acids multiple interactions ISO RGD:70502 6480464 Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased phosphorylation of TP53 protein] CTD PMID:24792323 aristolochic acids increases phosphorylation ISO RGD:70502 6480464 Aristolochic Acids results in increased phosphorylation of TP53 protein CTD PMID:24792323 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of TRP53 mRNA CTD PMID:25113976 Aroclor 1254 multiple interactions ISO RGD:3889 6480464 2-(1' more ... CTD PMID:35822628 Aroclor 1254 increases expression ISO RGD:3889 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of TP53 protein CTD PMID:35822628 arsane increases response to substance ISO RGD:70502 6480464 TP53 gene mutant form results in increased susceptibility to Arsenic, TP53 gene polymorphism results in increased susceptibility to Arsenic CTD PMID:16930632 , PMID:23643801 arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] promotes the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in increased expression of TRP53 mRNA] more ... CTD PMID:35714946 arsane multiple interactions ISO RGD:70502 6480464 [UNG protein affects the susceptibility to Arsenic] which affects the expression of TP53 protein more ... CTD PMID:34998823 arsane multiple interactions ISO RGD:3889 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TP53 mRNA more ... CTD PMID:31542844 , PMID:32402895 arsane increases mutagenesis ISO RGD:70502 6480464 Arsenic results in increased mutagenesis of TP53 exon, Arsenic results in increased mutagenesis of TP53 gene CTD PMID:15967209 more ... arsane affects localization EXP 6480464 Arsenic affects the localization of TRP53 protein CTD PMID:27289040 arsane decreases phosphorylation ISO RGD:70502 6480464 Arsenic results in decreased phosphorylation of TP53 protein CTD PMID:24473091 arsane affects response to substance ISO RGD:70502 6480464 TP53 polymorphism affects the susceptibility to Arsenic CTD PMID:21982800 arsane decreases expression ISO RGD:70502 6480464 Arsenic results in decreased expression of TP53 mRNA, Arsenic results in decreased expression of TP53 protein CTD PMID:19945496 , PMID:28785074 arsane increases methylation ISO RGD:70502 6480464 Arsenic results in increased methylation of TP53 promoter CTD PMID:16251483 , PMID:21756780 arsane increases expression ISO RGD:70502 6480464 Arsenic results in increased expression of TP53 mRNA more ... CTD PMID:12899209 more ... arsane decreases methylation ISO RGD:70502 6480464 Arsenic results in decreased methylation of TP53 exon CTD PMID:21756780 arsane affects expression ISO RGD:70502 6480464 Arsenic affects the expression of TP53 mRNA, Arsenic affects the expression of TP53 protein CTD PMID:17450239 , PMID:18414638 arsenic acid increases expression EXP 6480464 arsenic acid results in increased expression of TRP53 mRNA CTD PMID:8946558 arsenic atom affects expression ISO RGD:70502 6480464 Arsenic affects the expression of TP53 mRNA, Arsenic affects the expression of TP53 protein CTD PMID:17450239 , PMID:18414638 arsenic atom multiple interactions ISO RGD:70502 6480464 [UNG protein affects the susceptibility to Arsenic] which affects the expression of TP53 protein more ... CTD PMID:34998823 arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] promotes the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in increased expression of TRP53 mRNA] more ... CTD PMID:35714946 arsenic atom multiple interactions ISO RGD:3889 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TP53 mRNA more ... CTD PMID:31542844 , PMID:32402895 arsenic atom increases mutagenesis ISO RGD:70502 6480464 Arsenic results in increased mutagenesis of TP53 exon, Arsenic results in increased mutagenesis of TP53 gene CTD PMID:15967209 more ... arsenic atom affects localization EXP 6480464 Arsenic affects the localization of TRP53 protein CTD PMID:27289040 arsenic atom decreases phosphorylation ISO RGD:70502 6480464 Arsenic results in decreased phosphorylation of TP53 protein CTD PMID:24473091 arsenic atom increases methylation ISO RGD:70502 6480464 Arsenic results in increased methylation of TP53 promoter CTD PMID:16251483 , PMID:21756780 arsenic atom decreases methylation ISO RGD:70502 6480464 Arsenic results in decreased methylation of TP53 exon CTD PMID:21756780 arsenic atom affects response to substance ISO RGD:70502 6480464 TP53 polymorphism affects the susceptibility to Arsenic CTD PMID:21982800 arsenic atom increases response to substance ISO RGD:70502 6480464 TP53 gene mutant form results in increased susceptibility to Arsenic, TP53 gene polymorphism results in increased susceptibility to Arsenic CTD PMID:16930632 , PMID:23643801 arsenic atom increases expression ISO RGD:70502 6480464 Arsenic results in increased expression of TP53 mRNA more ... CTD PMID:12899209 more ... arsenic atom decreases expression ISO RGD:70502 6480464 Arsenic results in decreased expression of TP53 mRNA, Arsenic results in decreased expression of TP53 protein CTD PMID:19945496 , PMID:28785074 arsenic trichloride increases phosphorylation EXP 6480464 arsenic trichloride results in increased phosphorylation of TRP53 protein CTD PMID:16283526 arsenite(3-) decreases degradation EXP 6480464 arsenite results in decreased degradation of TRP53 protein CTD PMID:23396362 arsenite(3-) increases activity ISO RGD:70502 6480464 arsenite results in increased activity of TP53 protein CTD PMID:30177839 arsenite(3-) decreases phosphorylation ISO RGD:70502 6480464 arsenite results in decreased phosphorylation of TP53 protein CTD PMID:22447124 arsenite(3-) multiple interactions EXP 6480464 AKT1 protein modified form inhibits the reaction [arsenite results in increased expression of and results in increased phosphorylation of TRP53 protein] more ... CTD PMID:16739126 more ... arsenite(3-) affects methylation ISO RGD:70502 6480464 arsenite affects the methylation of TP53 promoter CTD PMID:11489357 arsenite(3-) increases expression ISO RGD:70502 6480464 arsenite results in increased expression of TP53 mRNA more ... CTD PMID:12126965 more ... arsenite(3-) multiple interactions ISO RGD:70502 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [arsenite promotes the reaction [TP53 protein binds to CREBBP protein]] more ... CTD PMID:12126965 more ... arsenous acid increases degradation ISO RGD:70502 6480464 Arsenic Trioxide results in increased degradation of TP53 protein CTD PMID:19457607 arsenous acid affects response to substance ISO RGD:70502 6480464 TP53 affects the susceptibility to Arsenic Trioxide, TP53 protein affects the susceptibility to Arsenic Trioxide CTD PMID:12851490 , PMID:29535630 arsenous acid decreases response to substance ISO RGD:70502 6480464 TP53 protein mutant form results in decreased susceptibility to Arsenic Trioxide CTD PMID:21454520 , PMID:24884809 arsenous acid increases activity ISO RGD:3889 6480464 Arsenic Trioxide results in increased activity of TP53 protein CTD PMID:17487067 arsenous acid increases phosphorylation EXP 6480464 Arsenic Trioxide results in increased phosphorylation of TP53 protein CTD PMID:27638049 arsenous acid multiple interactions ISO RGD:3889 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of TP53 protein] more ... CTD PMID:17487067 more ... arsenous acid affects expression ISO RGD:70502 6480464 Arsenic Trioxide affects the expression of TP53 CTD PMID:11775218 arsenous acid multiple interactions ISO RGD:70502 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of TP53 protein more ... CTD PMID:12851490 more ... arsenous acid increases phosphorylation ISO RGD:70502 6480464 Arsenic Trioxide results in increased phosphorylation of TP53 protein CTD PMID:29944906 , PMID:30472098 arsenous acid decreases expression ISO RGD:70502 6480464 Arsenic Trioxide results in decreased expression of TP53 mRNA more ... CTD PMID:21454520 more ... arsenous acid increases expression ISO RGD:70502 6480464 Arsenic Trioxide results in increased expression of TP53 mRNA more ... CTD PMID:10841286 more ... arsenous acid increases expression ISO RGD:3889 6480464 Arsenic Trioxide results in increased expression of TP53 mRNA, Arsenic Trioxide results in increased expression of TP53 protein CTD PMID:21145380 more ... arsenous acid increases phosphorylation ISO RGD:3889 6480464 Arsenic Trioxide results in increased phosphorylation of TP53 protein CTD PMID:23337567 arsenous acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in increased phosphorylation of TRP53 protein] more ... CTD PMID:21565247 , PMID:27638049 artesunate increases expression ISO RGD:70502 6480464 Artesunate results in increased expression of TP53 protein CTD PMID:33259807 artesunate multiple interactions ISO RGD:70502 6480464 Artesunate inhibits the reaction [TPT1 protein binds to TP53 protein] CTD PMID:33259807 asbestos affects response to substance ISO RGD:70502 6480464 TP53 gene SNP affects the susceptibility to Asbestos CTD PMID:23435014 asbestos increases expression ISO RGD:70502 6480464 Asbestos results in increased expression of TP53 protein CTD PMID:8049841 asbestos affects localization ISO RGD:70502 6480464 Asbestos affects the localization of TP53 protein CTD PMID:25466987 asbestos increases response to substance EXP 6480464 TRP53 gene mutant form results in increased susceptibility to Asbestos CTD PMID:15136429 aspartame increases expression EXP 6480464 Aspartame results in increased expression of TRP53, Aspartame results in increased expression of TRP53 mRNA CTD PMID:17354619 , PMID:32951320 aspartame multiple interactions EXP 6480464 [Fats more ... CTD PMID:23783067 astaxanthin multiple interactions ISO RGD:3889 6480464 astaxanthine inhibits the reaction [Cyclophosphamide results in increased expression of TP53 protein] CTD PMID:20038455 astilbin multiple interactions ISO RGD:70502 6480464 astilbin inhibits the reaction [Cisplatin results in increased expression of TP53 protein] CTD PMID:29471006 atorvastatin calcium increases expression ISO RGD:70502 6480464 Atorvastatin results in increased expression of TP53 protein CTD PMID:29630879 ATP multiple interactions ISO RGD:70502 6480464 TP53 protein inhibits the reaction [Deoxyglucose results in decreased abundance of Adenosine Triphosphate] CTD PMID:21042727 ATP increases abundance ISO RGD:70502 6480464 TP53 gene mutant form results in increased abundance of Adenosine Triphosphate CTD PMID:33070465 Atranorin decreases expression ISO RGD:70502 6480464 atranorin results in decreased expression of TP53 protein CTD PMID:22285236 atrasentan multiple interactions ISO RGD:3889 6480464 atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein] CTD PMID:22431579 atrazine increases expression ISO RGD:3889 6480464 Atrazine results in increased expression of TP53 mRNA, Atrazine results in increased expression of TP53 protein CTD PMID:30084861 , PMID:9486943 atrazine decreases expression ISO RGD:3889 6480464 Atrazine results in decreased expression of TP53 mRNA CTD PMID:34663174 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of TRP53 mRNA CTD PMID:33463082 atrazine increases expression EXP 6480464 Atrazine results in increased expression of TRP53 mRNA CTD PMID:33485040 atrazine decreases expression ISO RGD:70502 6480464 Atrazine results in decreased expression of TP53 mRNA, Atrazine results in decreased expression of TP53 protein CTD PMID:21333729 , PMID:22378314 atrazine multiple interactions ISO RGD:3889 6480464 kolaviron inhibits the reaction [Atrazine affects the expression of TP53] CTD PMID:21726175 atrazine affects expression ISO RGD:3889 6480464 Atrazine affects the expression of TP53 CTD PMID:21726175 atrazine multiple interactions ISO RGD:70502 6480464 kolaviron inhibits the reaction [Atrazine results in decreased expression of TP53 mRNA], kolaviron inhibits the reaction [Atrazine results in decreased expression of TP53 protein] CTD PMID:21333729 atrazine affects localization ISO RGD:3889 6480464 Atrazine affects the localization of TP53 protein CTD PMID:9486943 atropine multiple interactions ISO RGD:70502 6480464 Atropine inhibits the reaction [Malathion results in increased expression of TP53 protein], Atropine inhibits the reaction [Parathion results in increased expression of TP53 protein] CTD PMID:12762645 Auriculasin multiple interactions ISO RGD:70502 6480464 [TNFSF10 protein co-treated with auriculasin] results in increased expression of TP53 protein, TNFRSF10B protein affects the reaction [[TNFSF10 protein co-treated with auriculasin] results in increased expression of TP53 protein] CTD PMID:30817944 aurofusarin increases expression ISO RGD:70502 6480464 aurofusarin results in increased expression of TP53 protein CTD PMID:29248571 axitinib affects activity ISO RGD:70502 6480464 Axitinib affects the activity of TP53 protein CTD PMID:35435491 azadirachtin A increases expression ISO RGD:70502 6480464 azadirachtin results in increased expression of TP53 mRNA, azadirachtin results in increased expression of TP53 protein CTD PMID:20429769 azaribine affects activity ISO RGD:70502 6480464 azaribine affects the activity of TP53 protein CTD PMID:35435491 azathioprine increases expression ISO RGD:70502 6480464 Azathioprine results in increased expression of TP53 protein CTD PMID:14961032 azathioprine increases mutagenesis ISO RGD:70502 6480464 Azathioprine results in increased mutagenesis of TP53 gene CTD PMID:17979968 azetidine affects localization EXP 6480464 azetidine affects the localization of TRP53 protein CTD PMID:18813348 azinphos-ethyl affects activity ISO RGD:70502 6480464 azinphos ethyl metabolite affects the activity of TP53 protein CTD PMID:35435491 azinphos-methyl affects activity ISO RGD:70502 6480464 Azinphosmethyl metabolite affects the activity of TP53 protein CTD PMID:35435491 bafilomycin A1 multiple interactions ISO RGD:70502 6480464 [bafilomycin A1 co-treated with cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CASP3 protein, bafilomycin A1 inhibits the reaction [[cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CTSB protein] CTD PMID:23380477 baicalein increases expression ISO RGD:70502 6480464 baicalein results in increased expression of TP53 protein CTD PMID:21457722 baicalin increases expression ISO RGD:70502 6480464 baicalin results in increased expression of TP53 protein CTD PMID:21457722 barban affects activity ISO RGD:70502 6480464 barban affects the activity of TP53 protein CTD PMID:35435491 bathocuproine disulfonic acid multiple interactions ISO RGD:70502 6480464 bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid results in increased abundance of Copper] which results in increased oxidation of and results in increased expression of TP53 protein] CTD PMID:11964141 belinostat decreases expression ISO RGD:70502 6480464 belinostat results in decreased expression of TP53 mRNA CTD PMID:19606018 belinostat decreases expression EXP 6480464 belinostat results in decreased expression of TRP53 mRNA, belinostat results in decreased expression of TRP53 protein CTD PMID:29733868 benomyl affects activity ISO RGD:70502 6480464 Benomyl affects the activity of TP53 protein CTD PMID:35435491 Bensulide affects activity ISO RGD:70502 6480464 bensulide metabolite affects the activity of TP53 protein CTD PMID:35435491 benzalkonium chloride decreases expression ISO RGD:70502 6480464 Benzalkonium Compounds results in decreased expression of TP53 mRNA CTD PMID:28236482 benzene increases phosphorylation ISO RGD:70502 6480464 Benzene results in increased phosphorylation of TP53 protein CTD PMID:8076368 benzene multiple interactions ISO RGD:3889 6480464 Benzene results in increased phosphorylation of and results in increased activity of TP53 protein CTD PMID:9118908 benzene affects response to substance ISO RGD:70502 6480464 TP53 SNP affects the susceptibility to Benzene CTD PMID:18978339 benzene decreases expression ISO RGD:70502 6480464 Benzene results in decreased expression of TP53 mRNA CTD PMID:19505915 benzene increases mutagenesis ISO RGD:70502 6480464 Benzene results in increased mutagenesis of TP53 gene CTD PMID:19862502 benzene affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to Benzene CTD PMID:19326098 , PMID:20018183 benzene increases expression ISO RGD:70502 6480464 Benzene results in increased expression of TP53 mRNA CTD PMID:21382456 benzene multiple interactions EXP 6480464 TRP53 protein affects the reaction [Benzene results in decreased expression of CCR7 mRNA] more ... CTD PMID:11274754 more ... benzene increases response to substance EXP 6480464 TRP53 gene mutant form results in increased susceptibility to Benzene CTD PMID:19478238 benzene increases expression EXP 6480464 Benzene results in increased expression of TRP53 mRNA, Benzene results in increased expression of TRP53 protein CTD PMID:11896287 more ... benzene increases phosphorylation ISO RGD:3889 6480464 Benzene results in increased phosphorylation of TP53 protein CTD PMID:8076368 benzene increases expression ISO RGD:3889 6480464 Benzene results in increased expression of TP53 protein CTD PMID:18093815 benzene increases response to substance ISO RGD:70502 6480464 TP53 gene SNP results in increased susceptibility to Benzene CTD PMID:16728435 benzidine increases expression ISO RGD:70502 6480464 benzidine results in increased expression of TP53 protein mutant form CTD PMID:15748509 , PMID:17690521 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene metabolite results in increased expression of TRP53 protein modified form more ... CTD PMID:18656336 more ... benzo[a]pyrene decreases acetylation EXP 6480464 Benzo(a)pyrene results in decreased acetylation of TRP53 protein CTD PMID:28681665 benzo[a]pyrene affects methylation ISO RGD:70502 6480464 Benzo(a)pyrene affects the methylation of TP53 5' UTR CTD PMID:27901495 benzo[a]pyrene increases mutagenesis ISO RGD:3889 6480464 Benzo(a)pyrene results in increased mutagenesis of TP53 gene CTD PMID:9314051 benzo[a]pyrene increases response to substance EXP 6480464 TRP53 gene mutant form results in increased susceptibility to Benzo(a)pyrene CTD PMID:21715664 , PMID:25995008 benzo[a]pyrene increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to Benzo(a)pyrene CTD PMID:25398514 benzo[a]pyrene affects phosphorylation ISO RGD:70502 6480464 Benzo(a)pyrene affects the phosphorylation of TP53 protein CTD PMID:24362009 benzo[a]pyrene increases phosphorylation ISO RGD:70502 6480464 Benzo(a)pyrene results in increased phosphorylation of TP53 protein CTD PMID:15837074 more ... benzo[a]pyrene increases mutagenesis ISO RGD:70502 6480464 Benzo(a)pyrene results in increased mutagenesis of TP53 gene CTD PMID:22319594 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of TP53 protein, Benzo(a)pyrene results in decreased expression of TRP53 mRNA CTD PMID:20869020 more ... benzo[a]pyrene increases phosphorylation ISO RGD:3889 6480464 Benzo(a)pyrene results in increased phosphorylation of TP53 protein CTD PMID:17961608 more ... benzo[a]pyrene increases phosphorylation EXP 6480464 Benzo(a)pyrene results in increased phosphorylation of TRP53 protein CTD PMID:19041363 more ... benzo[a]pyrene affects expression ISO RGD:70502 6480464 Benzo(a)pyrene affects the expression of TP53 more ... CTD PMID:21393351 more ... benzo[a]pyrene increases activity ISO RGD:3889 6480464 Benzo(a)pyrene results in increased activity of TRP53 protein CTD PMID:19931295 benzo[a]pyrene affects localization ISO RGD:70502 6480464 Benzo(a)pyrene affects the localization of TP53 protein CTD PMID:20840854 benzo[a]pyrene affects response to substance ISO RGD:70502 6480464 TP53 affects the susceptibility to Benzo(a)pyrene, TP53 protein affects the susceptibility to Benzo(a)pyrene CTD PMID:10837373 more ... benzo[a]pyrene increases expression ISO RGD:70502 6480464 Benzo(a)pyrene metabolite results in increased expression of TP53 protein more ... CTD PMID:10837373 more ... benzo[a]pyrene increases expression ISO RGD:3889 6480464 Benzo(a)pyrene results in increased expression of TP53 mRNA more ... CTD PMID:19408242 more ... benzo[a]pyrene multiple interactions ISO RGD:3889 6480464 [Benzo(a)pyrene results in increased mutagenesis of TP53 gene] which affects the folding of TP53 protein more ... CTD PMID:15459018 more ... benzo[a]pyrene increases activity ISO RGD:70502 6480464 Benzo(a)pyrene results in increased activity of TP53 protein CTD PMID:12807757 benzo[a]pyrene affects activity ISO RGD:70502 6480464 Benzo(a)pyrene affects the activity of TP53 protein CTD PMID:20624995 benzo[a]pyrene decreases expression ISO RGD:70502 6480464 Benzo(a)pyrene results in decreased expression of TP53 mRNA, Benzo(a)pyrene results in decreased expression of TP53 protein CTD PMID:18247414 , PMID:29126329 benzo[a]pyrene affects localization EXP 6480464 Benzo(a)pyrene affects the localization of TRP53 protein CTD PMID:17240030 , PMID:9006915 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TRP53 mRNA more ... CTD PMID:11096091 more ... benzo[a]pyrene multiple interactions ISO RGD:70502 6480464 2 more ... CTD PMID:10837373 more ... benzo[a]pyrene diol epoxide I multiple interactions ISO RGD:70502 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [7 more ... CTD PMID:11782367 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:70502 6480464 7 more ... CTD PMID:34454013 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:19428948 benzo[a]pyrene diol epoxide I affects binding ISO RGD:70502 6480464 7 more ... CTD PMID:12727806 benzo[a]pyrene diol epoxide I increases phosphorylation ISO RGD:70502 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I increases expression ISO RGD:70502 6480464 7 more ... CTD PMID:11782367 more ... benzo[a]pyrene diol epoxide I affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to 7 more ... CTD PMID:21983885 Benzo[a]pyrene-7,8-diol multiple interactions ISO RGD:70502 6480464 [TP53 protein results in increased susceptibility to Etoposide] which results in decreased chemical synthesis of benzo(a)pyrene 7 more ... CTD PMID:15698582 , PMID:29471073 Benzo[a]pyrene-7,8-diol increases chemical synthesis ISO RGD:70502 6480464 TP53 protein results in increased chemical synthesis of benzo(a)pyrene 7, 8-dihydrodiol CTD PMID:29471073 benzo[b]fluoranthene increases expression ISO RGD:70502 6480464 benzo(b)fluoranthene results in increased expression of TP53 protein CTD PMID:21776270 benzo[b]fluoranthene affects activity ISO RGD:70502 6480464 benzo(b)fluoranthene affects the activity of TP53 protein, benzo(b)fluoranthene metabolite affects the activity of TP53 protein CTD PMID:35435491 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TRP53 mRNA CTD PMID:27858113 BENZO[G]CHRYSENE increases phosphorylation ISO RGD:3889 6480464 benzo(g)chrysene results in increased phosphorylation of TP53 protein CTD PMID:17961608 Benzo[k]fluoranthene affects activity ISO RGD:70502 6480464 benzo(k)fluoranthene affects the activity of TP53 protein, benzo(k)fluoranthene metabolite affects the activity of TP53 protein CTD PMID:35435491 berberine increases expression ISO RGD:70502 6480464 Berberine results in increased expression of TP53 mRNA, Berberine results in increased expression of TP53 protein CTD PMID:20656010 berberine multiple interactions ISO RGD:70502 6480464 [Berberine co-treated with Niacinamide] results in increased expression of and results in increased acetylation of TP53 protein, Berberine results in increased phosphorylation of and results in increased acetylation of TP53 protein CTD PMID:26712469 beryllium dichloride increases expression EXP 6480464 beryllium chloride results in increased expression of TRP53 mRNA CTD PMID:23793613 beryllium sulfate multiple interactions ISO RGD:70502 6480464 beryllium sulfate promotes the reaction [TP53 protein binds to CDKN1A promoter] CTD PMID:17395767 beryllium sulfate increases expression ISO RGD:70502 6480464 beryllium sulfate results in increased expression of TP53 protein CTD PMID:17395767 , PMID:20974702 Besigomsin multiple interactions EXP 6480464 schizandrol B inhibits the reaction [Acetaminophen results in increased activity of TRP53 protein], schizandrol B inhibits the reaction [Acetaminophen results in increased expression of and results in increased phosphorylation of TRP53 protein] CTD PMID:25319358 beta-carboline affects activity ISO RGD:70502 6480464 norharman metabolite affects the activity of TP53 protein CTD PMID:35435491 beta-naphthoflavone multiple interactions ISO RGD:70502 6480464 [beta-Naphthoflavone binds to and results in increased activity of AHR protein] results in decreased susceptibility to [1-nitropyrene results in increased expression of TP53 protein] CTD PMID:22044530 betalain increases expression ISO RGD:70502 6480464 Betalains results in increased expression of TP53 mRNA CTD PMID:33522684 betulinic acid increases expression ISO RGD:70502 6480464 Betulinic Acid results in increased expression of TP53 protein CTD PMID:33181113 betulinic acid multiple interactions ISO RGD:70502 6480464 [Betulinic Acid co-treated with Oxygen deficiency] results in increased expression of TP53 protein CTD PMID:33181113 bexarotene multiple interactions ISO RGD:70502 6480464 bexarotene results in increased phosphorylation of and results in increased activity of TP53 protein CTD PMID:19067706 bicalutamide increases expression ISO RGD:70502 6480464 bicalutamide results in increased expression of TP53 protein CTD PMID:15638997 bicalutamide multiple interactions ISO RGD:70502 6480464 bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of TP53 protein] CTD PMID:29383186 bifenthrin increases expression EXP 6480464 bifenthrin results in increased expression of TRP53 mRNA CTD PMID:20097460 , PMID:27916261 bifenthrin decreases expression EXP 6480464 bifenthrin results in decreased expression of TRP53 mRNA CTD PMID:26071804 biphenyl-2-ol multiple interactions ISO RGD:70502 6480464 [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene more ... CTD PMID:10334203 biphenyl-4-amine affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to 4-biphenylamine CTD PMID:11804609 biphenyl-4-amine decreases expression ISO RGD:70502 6480464 4-biphenylamine results in decreased expression of TP53 mRNA CTD PMID:32905825 biphenyl-4-amine affects expression ISO RGD:70502 6480464 4-biphenylamine affects the expression of TP53 protein CTD PMID:32905825 biphenyl-4-amine multiple interactions ISO RGD:70502 6480464 Acetylcysteine affects the reaction [4-biphenylamine affects the expression of TP53 protein] more ... CTD PMID:32905825 biphenyl-4-amine affects binding ISO RGD:70502 6480464 4-biphenylamine binds to TP53 gene CTD PMID:12376482 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of TRP53 protein CTD PMID:19560481 bis(2-chloroethyl) sulfide increases expression ISO RGD:70502 6480464 Mustard Gas results in increased expression of TP53 protein, Mustard Gas results in increased expression of TP53 protein modified form CTD PMID:11428642 more ... bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:70502 6480464 Mustard Gas results in increased phosphorylation of TP53 protein CTD PMID:19845377 more ... bis(2-chloroethyl) sulfide multiple interactions ISO RGD:70502 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Mustard Gas results in increased expression of TP53 protein] more ... CTD PMID:22119920 bis(2-ethylhexyl) phthalate increases expression ISO RGD:3889 6480464 Diethylhexyl Phthalate results in increased expression of TP53 mRNA CTD PMID:28115068 bis(2-ethylhexyl) phthalate increases expression ISO RGD:70502 6480464 Diethylhexyl Phthalate results in increased expression of TP53 protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:3889 6480464 Ethanol promotes the reaction [Diethylhexyl Phthalate results in increased expression of TP53 mRNA] CTD PMID:28115068 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 Diethylhexyl Phthalate inhibits the reaction [Selenomethionine results in decreased expression of TRP53 protein], Diethylhexyl Phthalate inhibits the reaction [Sodium Selenite results in decreased expression of TRP53 protein] CTD PMID:20659492 Bisoxatin acetate affects activity ISO RGD:70502 6480464 bisoxatin acetate affects the activity of TP53 protein CTD PMID:35435491 bisphenol A increases expression ISO RGD:3889 6480464 bisphenol A results in increased expression of TP53 mRNA more ... CTD PMID:23146694 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of TRP53 protein CTD PMID:33509759 bisphenol A increases phosphorylation ISO RGD:70502 6480464 bisphenol A results in increased phosphorylation of TP53 protein CTD PMID:29275510 more ... bisphenol A increases methylation ISO RGD:3889 6480464 bisphenol A results in increased methylation of TP53 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:70502 6480464 bisphenol A analog results in increased expression of TP53 mRNA more ... CTD PMID:21277958 more ... bisphenol A affects expression ISO RGD:3889 6480464 bisphenol A affects the expression of TP53 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:3889 6480464 [bisphenol A co-treated with naringin] results in decreased expression of TP53 protein more ... CTD PMID:25454643 more ... bisphenol A decreases expression ISO RGD:3889 6480464 bisphenol A analog results in decreased expression of TP53 mRNA more ... CTD PMID:26982218 more ... bisphenol A multiple interactions ISO RGD:70502 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased phosphorylation of TP53 protein] more ... CTD PMID:23222814 more ... bisphenol A decreases expression ISO RGD:70502 6480464 bisphenol A results in decreased expression of TP53 mRNA, bisphenol A results in decreased expression of TP53 protein CTD PMID:23222814 more ... bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of TRP53 protein CTD PMID:29102535 bisphenol F decreases expression ISO RGD:70502 6480464 bisphenol F results in decreased expression of TP53 mRNA CTD PMID:31875995 bisphenol F diglycidyl ether affects activity ISO RGD:70502 6480464 bisphenol F diglycidyl ether affects the activity of TP53 protein CTD PMID:35435491 bithionol affects activity ISO RGD:70502 6480464 Bithionol affects the activity of TP53 protein CTD PMID:35435491 bleomycin A2 increases expression ISO RGD:70502 6480464 Bleomycin results in increased expression of TP53 mRNA CTD PMID:26800624 bleomycin A2 increases phosphorylation ISO RGD:70502 6480464 Bleomycin results in increased phosphorylation of TP53 protein CTD PMID:24933654 bleomycin A2 multiple interactions ISO RGD:70502 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Bleomycin promotes the reaction [resveratrol results in increased phosphorylation of TP53 protein]] more ... CTD PMID:24933654 , PMID:26800624 bleomycin A2 increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to Bleomycin CTD PMID:20135637 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of TRP53 protein CTD PMID:9683175 boric acid decreases expression EXP 6480464 boric acid results in decreased expression of TRP53 mRNA CTD PMID:31368021 bortezomib multiple interactions ISO RGD:70502 6480464 [CASP8 protein results in increased activity of CASP3 protein] affects the reaction [Bortezomib results in increased phosphorylation of TP53 protein] more ... CTD PMID:12393500 more ... bortezomib affects activity ISO RGD:70502 6480464 Bortezomib affects the activity of TP53 protein CTD PMID:35435491 bortezomib increases activity ISO RGD:70502 6480464 Bortezomib results in increased activity of TP53 protein CTD PMID:30818834 bortezomib multiple interactions EXP 6480464 [SCIO-469 co-treated with Bortezomib] results in increased expression of TRP53 protein CTD PMID:16617327 bortezomib increases stability ISO RGD:70502 6480464 Bortezomib results in increased stability of TP53 protein CTD PMID:15543232 bortezomib increases expression ISO RGD:70502 6480464 Bortezomib results in increased expression of TP53 protein CTD PMID:12393500 more ... bosutinib affects activity ISO RGD:70502 6480464 bosutinib analog affects the activity of TP53 protein CTD PMID:35435491 brassinolide increases expression ISO RGD:70502 6480464 brassinolide results in increased expression of TP53 protein CTD PMID:20833159 bromochloroacetic acid multiple interactions ISO RGD:3889 6480464 bromochloroacetic acid promotes the reaction [Bromates results in increased phosphorylation of TP53 protein] CTD PMID:21864635 Bromofos affects activity ISO RGD:70502 6480464 bromophos metabolite affects the activity of TP53 protein CTD PMID:35435491 Bromophos-ethyl affects activity ISO RGD:70502 6480464 ethyl bromophos affects the activity of TP53 protein, ethyl bromophos metabolite affects the activity of TP53 protein CTD PMID:35435491 bromuconazole increases expression ISO RGD:3889 6480464 bromuconazole results in increased expression of TP53 mRNA CTD PMID:36370923 bucladesine multiple interactions ISO RGD:70502 6480464 [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of TP53 protein, [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of TP53 protein CTD PMID:22534328 budesonide decreases expression ISO RGD:70502 6480464 Budesonide results in decreased expression of TP53 protein CTD PMID:15475437 buspirone decreases expression ISO RGD:3889 6480464 Buspirone results in decreased expression of TP53 mRNA CTD PMID:24136188 busulfan multiple interactions ISO RGD:70502 6480464 Busulfan affects the phosphorylation of and affects the activity of TP53 protein CTD PMID:16882877 busulfan increases expression ISO RGD:70502 6480464 Busulfan results in increased expression of TP53 mRNA CTD PMID:35641671 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of TRP53 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:70502 6480464 butyraldehyde results in decreased expression of TP53 mRNA CTD PMID:26079696 butylated hydroxyanisole multiple interactions ISO RGD:3889 6480464 Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TP53 protein] CTD PMID:18593901 butylated hydroxyanisole multiple interactions EXP 6480464 Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein] CTD PMID:18593901 Butylbenzyl phthalate increases methylation ISO RGD:70502 6480464 butylbenzyl phthalate results in increased methylation of TP53 promoter CTD PMID:35487445 Butylbenzyl phthalate decreases expression ISO RGD:70502 6480464 butylbenzyl phthalate results in decreased expression of TP53 mRNA CTD PMID:31016752 , PMID:35487445 butyric acid multiple interactions ISO RGD:70502 6480464 [1'-acetoxychavicol acetate co-treated with Butyric Acid] results in increased phosphorylation of TP53 protein CTD PMID:24480522 butyric acid decreases expression ISO RGD:70502 6480464 Butyric Acid results in decreased expression of TP53 mRNA CTD PMID:34581912 butyric acid multiple interactions EXP 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 C.I. Natural Red 20 increases expression ISO RGD:70502 6480464 shikonin results in increased expression of TP53 protein CTD PMID:28684144 C60 fullerene decreases expression ISO RGD:3889 6480464 fullerene C60 results in decreased expression of TP53 mRNA CTD PMID:19167457 C60 fullerene multiple interactions ISO RGD:70502 6480464 fullerene C60 analog results in increased phosphorylation of and results in increased expression of TP53 protein CTD PMID:20045429 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of TP53 protein, Cadmium results in increased expression of TRP53 protein CTD PMID:12189181 more ... cadmium atom increases activity EXP 6480464 Cadmium results in increased activity of TRP53 protein CTD PMID:22634143 cadmium atom affects folding EXP 6480464 Cadmium affects the folding of TRP53 protein CTD PMID:8467489 cadmium atom increases phosphorylation ISO RGD:3889 6480464 Cadmium results in increased phosphorylation of TP53 protein CTD PMID:18463101 , PMID:27658547 cadmium atom increases expression ISO RGD:3889 6480464 Cadmium results in increased expression of TP53 protein CTD PMID:24212999 cadmium atom multiple interactions ISO RGD:3889 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of and affects the localization of TP53 protein more ... CTD PMID:18463101 more ... cadmium atom increases expression ISO RGD:70502 6480464 Cadmium results in increased expression of TP53 protein CTD PMID:12189181 , PMID:32976933 cadmium atom decreases activity EXP 6480464 Cadmium results in decreased activity of TRP53 protein CTD PMID:10531375 cadmium atom increases activity ISO RGD:3889 6480464 Cadmium results in increased activity of TP53 protein CTD PMID:16730872 cadmium atom affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to Cadmium CTD PMID:17174997 cadmium atom multiple interactions ISO RGD:70502 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the folding of TP53 protein more ... CTD PMID:10531375 more ... cadmium atom affects localization ISO RGD:70502 6480464 Cadmium affects the localization of TP53 protein CTD PMID:25101185 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRP53 protein more ... CTD PMID:12189181 more ... cadmium dichloride affects phosphorylation ISO RGD:70502 6480464 Cadmium Chloride affects the phosphorylation of TP53 protein CTD PMID:23941782 cadmium dichloride increases acetylation ISO RGD:3889 6480464 Cadmium Chloride results in increased acetylation of TP53 protein CTD PMID:36493885 cadmium dichloride decreases expression ISO RGD:3889 6480464 Cadmium Chloride results in decreased expression of TP53 mRNA CTD PMID:30606898 , PMID:31077537 cadmium dichloride affects activity ISO RGD:70502 6480464 Cadmium Chloride affects the activity of TP53 protein CTD PMID:25596134 cadmium dichloride decreases activity ISO RGD:70502 6480464 Cadmium Chloride results in decreased activity of TP53 protein CTD PMID:25446071 cadmium dichloride affects expression ISO RGD:3889 6480464 Cadmium Chloride affects the expression of TP53 mRNA CTD PMID:10647914 cadmium dichloride increases expression ISO RGD:3889 6480464 Cadmium Chloride results in increased expression of TP53 mRNA, Cadmium Chloride results in increased expression of TP53 protein CTD PMID:16600092 more ... cadmium dichloride affects localization ISO RGD:70502 6480464 Cadmium Chloride affects the localization of TP53 protein CTD PMID:25118938 cadmium dichloride increases activity EXP 6480464 Cadmium Chloride results in increased activity of TRP53 protein CTD PMID:23376140 cadmium dichloride increases expression ISO RGD:70502 6480464 Cadmium Chloride results in increased expression of TP53 mRNA, Cadmium Chloride results in increased expression of TP53 protein CTD PMID:12676607 more ... cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of TP53 protein more ... CTD PMID:15501611 more ... cadmium dichloride affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to Cadmium Chloride CTD PMID:21252392 cadmium dichloride decreases activity EXP 6480464 Cadmium Chloride results in decreased activity of TRP53 protein CTD PMID:10531375 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRP53 protein more ... CTD PMID:11516527 more ... cadmium dichloride multiple interactions ISO RGD:3889 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of TP53 mRNA more ... CTD PMID:16600092 more ... cadmium dichloride affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to Cadmium Chloride CTD PMID:17174997 cadmium dichloride increases activity ISO RGD:3889 6480464 Cadmium Chloride results in increased activity of TP53 protein CTD PMID:16730872 cadmium dichloride increases phosphorylation ISO RGD:70502 6480464 Cadmium Chloride results in increased phosphorylation of TP53 protein CTD PMID:12676607 cadmium dichloride multiple interactions ISO RGD:70502 6480464 [Cadmium Chloride results in decreased activity of TP53 protein] inhibits the reaction [TP53 protein binds to TP53 gene] more ... CTD PMID:10531375 more ... caffeine multiple interactions ISO RGD:70502 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Caffeine inhibits the reaction [2 more ... CTD PMID:12393500 more ... caffeine decreases phosphorylation ISO RGD:70502 6480464 Caffeine results in decreased phosphorylation of TP53 protein CTD PMID:35688186 caffeine multiple interactions EXP 6480464 3-(2 more ... CTD PMID:12907610 , PMID:30555576 caffeine decreases mutagenesis EXP 6480464 Caffeine results in decreased mutagenesis of TRP53 gene CTD PMID:15975959 caffeine multiple interactions ISO RGD:3889 6480464 Caffeine inhibits the reaction [Diethylnitrosamine results in increased expression of TP53 protein], Caffeine inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of TP53 protein] CTD PMID:11751435 caffeine increases phosphorylation ISO RGD:70502 6480464 Caffeine results in increased phosphorylation of TP53 protein CTD PMID:12811820 Calcimycin increases expression ISO RGD:70502 6480464 Calcimycin results in increased expression of TP53 mRNA CTD PMID:26419736 Calcimycin multiple interactions ISO RGD:70502 6480464 [[Air Pollutants results in increased abundance of Particulate Matter] which co-treated with Calcimycin] affects the expression of TP53 mRNA CTD PMID:26419736 calcitriol increases expression ISO RGD:70502 6480464 Calcitriol results in increased expression of TP53 protein CTD PMID:12071473 calcium atom decreases expression ISO RGD:70502 6480464 Calcium results in decreased expression of TP53 protein CTD PMID:16043423 calcium atom affects localization ISO RGD:70502 6480464 TP53 protein affects the localization of Calcium CTD PMID:15059885 calcium silicate increases expression EXP 6480464 calcium silicate results in increased expression of TRP53 mRNA CTD PMID:29279043 calcium(0) decreases expression ISO RGD:70502 6480464 Calcium results in decreased expression of TP53 protein CTD PMID:16043423 calcium(0) affects localization ISO RGD:70502 6480464 TP53 protein affects the localization of Calcium CTD PMID:15059885 calyculin a multiple interactions ISO RGD:70502 6480464 calyculin A inhibits the reaction [N-caproylsphingosine affects the splicing of and results in increased expression of TP53 mRNA], calyculin A inhibits the reaction [N-caproylsphingosine results in increased expression of TP53 protein modified form] CTD PMID:25195822 camptothecin multiple interactions ISO RGD:3889 6480464 Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein] more ... CTD PMID:11279278 , PMID:13679428 camptothecin affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to Camptothecin CTD PMID:20477944 camptothecin increases expression ISO RGD:70502 6480464 Camptothecin results in increased expression of TP53 protein CTD PMID:12082016 more ... camptothecin decreases acetylation ISO RGD:70502 6480464 Camptothecin results in decreased acetylation of TP53 protein CTD PMID:24726431 camptothecin increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to Camptothecin CTD PMID:23285096 , PMID:9673414 camptothecin increases phosphorylation ISO RGD:3889 6480464 Camptothecin results in increased phosphorylation of TP53 protein CTD PMID:13679428 camptothecin increases activity ISO RGD:3889 6480464 Camptothecin results in increased activity of TP53 protein CTD PMID:11279278 , PMID:13679428 camptothecin increases glutathionylation ISO RGD:70502 6480464 Camptothecin results in increased glutathionylation of TP53 protein CTD PMID:17555331 camptothecin multiple interactions ISO RGD:70502 6480464 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in increased expression of TP53 protein] more ... CTD PMID:11741290 more ... camptothecin increases phosphorylation ISO RGD:70502 6480464 Camptothecin results in increased phosphorylation of TP53 protein CTD PMID:17555331 , PMID:26657896 camptothecin decreases response to substance ISO RGD:70502 6480464 TP53 mutant form results in decreased susceptibility to Camptothecin more ... CTD PMID:10692111 more ... candesartan increases expression ISO RGD:3889 6480464 candesartan results in increased expression of TP53 mRNA, candesartan results in increased expression of TP53 protein CTD PMID:11409658 cannabidiol decreases expression ISO RGD:3889 6480464 Cannabidiol results in decreased expression of TP53 mRNA CTD PMID:32553926 cannabidiol increases expression ISO RGD:70502 6480464 Cannabidiol results in increased expression of TP53 mRNA, Cannabidiol results in increased expression of TP53 protein CTD PMID:27918106 , PMID:32992648 cannabidiol decreases expression ISO RGD:70502 6480464 Cannabidiol results in decreased expression of TP53 mRNA, Cannabidiol results in decreased expression of TP53 protein CTD PMID:30713602 more ... cannabidiol multiple interactions ISO RGD:70502 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of TP53 mRNA more ... CTD PMID:30096889 more ... capsaicin increases expression ISO RGD:70502 6480464 Capsaicin results in increased expression of TP53 mRNA, Capsaicin results in increased expression of TP53 protein CTD PMID:16540674 more ... capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of TRP53 CTD PMID:20069556 capsaicin decreases degradation ISO RGD:70502 6480464 Capsaicin results in decreased degradation of TP53 protein CTD PMID:17292493 capsaicin increases degradation ISO RGD:70502 6480464 Capsaicin results in increased degradation of TP53 protein CTD PMID:19699254 capsaicin affects response to substance ISO RGD:70502 6480464 TP53 affects the susceptibility to Capsaicin CTD PMID:19846903 capsaicin increases phosphorylation ISO RGD:70502 6480464 Capsaicin results in increased phosphorylation of TP53 protein CTD PMID:14871840 capsaicin multiple interactions ISO RGD:70502 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein] more ... CTD PMID:14871840 more ... carbachol multiple interactions EXP 6480464 Carbachol inhibits the reaction [APP protein modified form results in increased expression of TRP53 protein] CTD PMID:10758335 carbamate ester multiple interactions ISO RGD:70502 6480464 Carbamates analog promotes the reaction [ATM protein results in increased phosphorylation of and results in increased activity of TP53 protein], Carbamates analog results in increased phosphorylation of and results in increased activity of TP53 protein CTD PMID:19376255 carbamate ester increases phosphorylation EXP 6480464 Carbamates analog results in increased phosphorylation of TRP53 protein CTD PMID:19197993 carbamate ester affects expression EXP 6480464 Carbamates affects the expression of TRP53 protein CTD PMID:21303328 carbamazepine affects expression ISO RGD:70502 6480464 Carbamazepine affects the expression of TP53 mRNA CTD PMID:24752500 carbendazim increases expression ISO RGD:3889 6480464 carbendazim results in increased expression of TP53 mRNA CTD PMID:35513110 carbendazim affects activity ISO RGD:70502 6480464 carbendazim affects the activity of TP53 protein CTD PMID:35435491 CARBENOXOLONE affects expression ISO RGD:70502 6480464 Carbenoxolone affects the expression of TP53 mRNA CTD PMID:23678415 carbofuran multiple interactions ISO RGD:70502 6480464 Carbofuran results in decreased stability of and results in increased degradation of and results in increased mutagenesis of TP53 gene CTD PMID:22445671 carbon nanotube multiple interactions ISO RGD:70502 6480464 Nanotubes, Carbon results in decreased expression of and results in increased phosphorylation of TP53 protein CTD PMID:23634900 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:70502 6480464 Nanotubes, Carbon results in decreased expression of TP53 mRNA CTD PMID:15585362 Carbophenothion affects activity ISO RGD:70502 6480464 carbophenothion metabolite affects the activity of TP53 protein CTD PMID:35435491 carboplatin increases expression ISO RGD:70502 6480464 Carboplatin results in increased expression of TP53 mRNA, Carboplatin results in increased expression of TP53 protein CTD PMID:15131059 more ... carboplatin multiple interactions ISO RGD:70502 6480464 [Carboplatin co-treated with Gallic Acid] results in increased expression of TP53 protein more ... CTD PMID:33002289 carfilzomib increases activity ISO RGD:70502 6480464 carfilzomib results in increased activity of TP53 protein CTD PMID:30818834 carfilzomib affects activity ISO RGD:70502 6480464 carfilzomib affects the activity of TP53 protein CTD PMID:35435491 Carmofur affects activity ISO RGD:70502 6480464 carmofur affects the activity of TP53 protein CTD PMID:35435491 carmustine increases expression ISO RGD:70502 6480464 Carmustine results in increased expression of TP53 protein CTD PMID:15735757 more ... carmustine increases response to substance ISO RGD:70502 6480464 TP53 results in increased susceptibility to Carmustine CTD PMID:10455409 carmustine decreases response to substance ISO RGD:70502 6480464 TP53 protein results in decreased susceptibility to Carmustine CTD PMID:16193384 carmustine affects response to substance ISO RGD:70502 6480464 TP53 protein modified form affects the susceptibility to Carmustine CTD PMID:11861384 carmustine multiple interactions ISO RGD:70502 6480464 [Carmustine co-treated with O(6)-benzylguanine] results in increased expression of TP53 protein, MDM4 protein promotes the reaction [Carmustine results in increased expression of TP53 protein] CTD PMID:15735757 , PMID:20472715 carvedilol affects expression ISO RGD:3889 6480464 carvedilol affects the expression of TP53 protein CTD PMID:22000973 carvedilol multiple interactions ISO RGD:3889 6480464 carvedilol inhibits the reaction [Potassium Dichromate results in increased expression of TP53 protein] CTD PMID:25245570 casticin increases expression ISO RGD:70502 6480464 casticin results in increased expression of TP53 protein modified form CTD PMID:29098808 casticin decreases expression ISO RGD:70502 6480464 casticin results in decreased expression of TP53 protein CTD PMID:29098808 cefalotin increases expression ISO RGD:70502 6480464 Cephalothin results in increased expression of TP53 protein CTD PMID:15012731 cefotaxime increases expression ISO RGD:70502 6480464 Cefotaxime results in increased expression of TP53 protein CTD PMID:15012731 celastrol multiple interactions ISO RGD:70502 6480464 Uridine inhibits the reaction [celastrol results in increased expression of TP53 protein] CTD PMID:27374097 celastrol increases expression ISO RGD:70502 6480464 celastrol results in increased expression of TP53 protein CTD PMID:27374097 celecoxib increases expression ISO RGD:70502 6480464 Celecoxib results in increased expression of TP53 mRNA, Celecoxib results in increased expression of TP53 protein CTD PMID:18202791 , PMID:19706164 celecoxib multiple interactions ISO RGD:3889 6480464 Celecoxib inhibits the reaction [Gentamicins results in increased expression of TP53 protein] CTD PMID:31628940 celecoxib multiple interactions EXP 6480464 [Celecoxib co-treated with docetaxel] results in increased expression of TRP53 protein, Celecoxib promotes the reaction [Doxorubicin results in increased expression of TRP53 protein] CTD PMID:15458769 , PMID:16052515 celecoxib increases response to substance ISO RGD:70502 6480464 TP53 results in increased susceptibility to Celecoxib CTD PMID:19706164 celecoxib multiple interactions ISO RGD:70502 6480464 [FEC protocol co-treated with Celecoxib] results in decreased expression of TP53 protein more ... CTD PMID:16507397 more ... cepharanthine increases expression ISO RGD:70502 6480464 cepharanthine results in increased expression of TP53 protein CTD PMID:31255635 ceric oxide increases phosphorylation ISO RGD:70502 6480464 ceric oxide results in increased phosphorylation of TP53 protein CTD PMID:24987704 cerium decreases expression ISO RGD:70502 6480464 Cerium results in decreased expression of TP53 mRNA CTD PMID:35641671 cetrorelix increases expression ISO RGD:70502 6480464 cetrorelix results in increased expression of TP53 protein CTD PMID:21062912 CGS-21680 multiple interactions ISO RGD:70502 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Caffeine inhibits the reaction [2, 2'-azobis(2-amidinopropane) results in increased phosphorylation of TP53 protein]] CTD PMID:30555576 chalcones increases expression ISO RGD:70502 6480464 Chalcones analog results in increased expression of TP53 mRNA CTD PMID:32856275 chlorambucil increases expression ISO RGD:70502 6480464 Chlorambucil results in increased expression of TP53, Chlorambucil results in increased expression of TP53 protein CTD PMID:18092340 , PMID:8822937 chlorambucil affects activity ISO RGD:70502 6480464 Chlorambucil affects the activity of TP53 protein CTD PMID:35435491 chlorambucil multiple interactions ISO RGD:70502 6480464 [Theophylline co-treated with Chlorambucil] results in increased expression of TP53, IL4 protein inhibits the reaction [[Theophylline co-treated with Chlorambucil] results in increased expression of TP53] CTD PMID:8822937 chlorfenvinfos affects activity ISO RGD:70502 6480464 Chlorfenvinphos metabolite affects the activity of TP53 protein CTD PMID:35435491 chloroacetaldehyde affects activity ISO RGD:70502 6480464 chloroacetaldehyde affects the activity of TP53 protein CTD PMID:25596134 chloroethene multiple interactions ISO RGD:70502 6480464 CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride affects the mutagenesis of TP53 gene] more ... CTD PMID:12010862 more ... chloroethene affects response to substance ISO RGD:70502 6480464 TP53 polymorphism affects the susceptibility to Vinyl Chloride CTD PMID:24464562 chloroethene decreases expression ISO RGD:70502 6480464 Vinyl Chloride results in decreased expression of TP53 mRNA CTD PMID:22076037 chloroethene increases expression ISO RGD:70502 6480464 Vinyl Chloride results in increased expression of TP53 protein, Vinyl Chloride results in increased expression of TP53 protein mutant form CTD PMID:12670519 more ... chloroethene increases mutagenesis ISO RGD:70502 6480464 Vinyl Chloride results in increased mutagenesis of TP53 gene CTD PMID:12010862 more ... chloroethene increases response to substance ISO RGD:70502 6480464 TP53 gene SNP results in increased susceptibility to Vinyl Chloride CTD PMID:18226366 chloroform increases expression ISO RGD:3889 6480464 Chloroform results in increased expression of TP53 mRNA CTD PMID:17522070 chloroform increases phosphorylation ISO RGD:3889 6480464 Chloroform results in increased phosphorylation of TP53 protein CTD PMID:8076368 chloroform increases phosphorylation ISO RGD:70502 6480464 Chloroform results in increased phosphorylation of TP53 protein CTD PMID:8076368 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of TRP53 protein] CTD PMID:25043994 chlorogenic acid increases expression EXP 6480464 Chlorogenic Acid results in increased expression of TRP53 mRNA CTD PMID:33058431 chloropicrin increases expression ISO RGD:70502 6480464 chloropicrin results in increased expression of TP53 protein CTD PMID:22516760 , PMID:24548678 chloropicrin increases phosphorylation ISO RGD:70502 6480464 chloropicrin results in increased phosphorylation of TP53 protein CTD PMID:31884112 chloroquine increases activity ISO RGD:70502 6480464 Chloroquine results in increased activity of TP53, Chloroquine results in increased activity of TP53 protein CTD PMID:12082016 , PMID:18089834 chloroquine multiple interactions ISO RGD:70502 6480464 Chloroquine inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] CTD PMID:22927544 chloroquine multiple interactions EXP 6480464 TRP53 mutant form inhibits the reaction [Chloroquine results in increased activity of CASP3 protein] CTD PMID:11589424 chlorpromazine affects activity ISO RGD:3889 6480464 Chlorpromazine affects the activity of TP53 protein CTD PMID:25596134 chlorpyrifos increases expression ISO RGD:3889 6480464 Chlorpyrifos results in increased expression of TP53 mRNA CTD PMID:12464398 , PMID:17452286 chlorpyrifos affects activity ISO RGD:70502 6480464 Chlorpyrifos metabolite affects the activity of TP53 protein CTD PMID:35435491 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of TRP53 mRNA CTD PMID:30378422 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of TRP53 mRNA CTD PMID:30378422 chlorpyrifos multiple interactions EXP 6480464 BBC3 gene mutant form inhibits the reaction [Chlorpyrifos results in increased expression of TRP53 mRNA] more ... CTD PMID:32120800 , PMID:34289071 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of TRP53 mRNA, Chlorpyrifos results in increased expression of TRP53 protein CTD PMID:32120800 , PMID:34289071 chlorpyrifos increases expression ISO RGD:70502 6480464 Chlorpyrifos results in increased expression of TP53 mRNA CTD PMID:30981936 chlorpyrifos decreases expression ISO RGD:70502 6480464 Chlorpyrifos results in decreased expression of TP53 protein CTD PMID:27993609 chlorpyrifos multiple interactions ISO RGD:70502 6480464 [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with glyphosate] results in decreased susceptibility to Cisplatin] which results in decreased expression of TP53 mRNA more ... CTD PMID:27993609 , PMID:32800223 chlorpyrifos-methyl affects activity ISO RGD:70502 6480464 chlorpyrifos-methyl metabolite affects the activity of TP53 protein CTD PMID:35435491 cholesterol multiple interactions ISO RGD:70502 6480464 [[[EGF protein binds to 1 more ... CTD PMID:35385781 choline decreases expression ISO RGD:3889 6480464 Choline results in decreased expression of TP53 mRNA CTD PMID:16014740 choline decreases expression EXP 6480464 Choline results in decreased expression of TRP53 mRNA CTD PMID:16014740 chromium atom multiple interactions ISO RGD:70502 6480464 CDKN1A affects the reaction [Chromium results in increased expression of TP53 protein] more ... CTD PMID:18024214 , PMID:18602874 chromium atom increases expression ISO RGD:70502 6480464 Chromium results in increased expression of TP53 protein CTD PMID:18024214 chromium(6+) increases response to substance EXP 6480464 TRP53 protein results in increased susceptibility to chromium hexavalent ion CTD PMID:12324196 chromium(6+) multiple interactions EXP 6480464 [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased phosphorylation of TRP53 protein, Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased phosphorylation of TRP53 protein] CTD PMID:35643323 chromium(6+) multiple interactions ISO RGD:3889 6480464 [6-chloro-2 more ... CTD PMID:35307491 chromium(6+) increases expression ISO RGD:3889 6480464 chromium hexavalent ion results in increased expression of TP53 protein CTD PMID:32679048 chromium(6+) increases stability ISO RGD:70502 6480464 chromium hexavalent ion results in increased stability of TP53 protein CTD PMID:31388677 chromium(6+) increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to chromium hexavalent ion CTD PMID:10574974 , PMID:16166740 chromium(6+) increases expression ISO RGD:70502 6480464 chromium hexavalent ion results in increased expression of TP53 mRNA, chromium hexavalent ion results in increased expression of TP53 protein CTD PMID:10788560 more ... chromium(6+) multiple interactions ISO RGD:70502 6480464 [chromium hexavalent ion binds to TP53 gene] which results in increased mutagenesis of TP53 gene more ... CTD PMID:14971653 more ... chromium(6+) affects binding ISO RGD:70502 6480464 chromium hexavalent ion binds to TP53 gene CTD PMID:22791815 chromium(6+) increases activity ISO RGD:70502 6480464 chromium hexavalent ion results in increased activity of TP53 protein CTD PMID:10574974 chromium(6+) increases mutagenesis ISO RGD:70502 6480464 chromium hexavalent ion results in increased mutagenesis of TP53 gene CTD PMID:22791815 chromium(6+) decreases expression ISO RGD:70502 6480464 chromium hexavalent ion results in decreased expression of TP53 protein CTD PMID:22666341 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TRP53 mRNA, chrysene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 protein] CTD PMID:22120587 , PMID:27858113 chrysene increases expression EXP 6480464 chrysene results in increased expression of TRP53 protein CTD PMID:22120587 chrysin increases degradation ISO RGD:70502 6480464 chrysin results in increased degradation of TP53 protein CTD PMID:14634213 chrysin affects activity ISO RGD:70502 6480464 chrysin affects the activity of TP53 protein CTD PMID:35435491 chrysin multiple interactions ISO RGD:70502 6480464 [Cisplatin co-treated with chrysin] affects the localization of TP53 protein more ... CTD PMID:25770930 chrysin multiple interactions ISO RGD:3889 6480464 [Diethylnitrosamine co-treated with chrysin] results in increased expression of TP53 protein more ... CTD PMID:21167192 , PMID:29247772 chrysin 5,7-dimethyl ether multiple interactions ISO RGD:3889 6480464 [5 more ... CTD PMID:21554863 ciclopirox affects activity ISO RGD:70502 6480464 Ciclopirox affects the activity of TP53 protein CTD PMID:35435491 cidofovir anhydrous affects activity ISO RGD:70502 6480464 Cidofovir affects the activity of TP53 protein CTD PMID:25596134 cidofovir anhydrous increases expression ISO RGD:70502 6480464 Cidofovir results in increased expression of TP53 protein CTD PMID:11697818 cilostazol increases expression ISO RGD:70502 6480464 cilostazol results in increased expression of TP53 protein CTD PMID:10642304 cilostazol multiple interactions ISO RGD:3889 6480464 cilostazol inhibits the reaction [Nitroprusside results in increased phosphorylation of TP53 protein] CTD PMID:18311796 Cirsimarin decreases expression ISO RGD:70502 6480464 cirsimarin results in decreased expression of TP53 mRNA CTD PMID:35710092 cis-caffeic acid affects expression ISO RGD:70502 6480464 caffeic acid affects the expression of TP53 protein CTD PMID:11522280 cis-caffeic acid multiple interactions ISO RGD:70502 6480464 caffeic acid promotes the reaction [Thapsigargin results in decreased expression of TP53 mRNA] CTD PMID:19442820 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of TRP53 more ... CTD PMID:18558085 more ... cisplatin increases stability ISO RGD:70502 6480464 Cisplatin results in increased stability of TP53 protein CTD PMID:32238696 cisplatin affects activity ISO RGD:70502 6480464 Cisplatin affects the activity of TP53 protein CTD PMID:25596134 cisplatin affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to Cisplatin CTD PMID:12185594 more ... cisplatin affects localization EXP 6480464 Cisplatin affects the localization of TRP53 protein, Cisplatin affects the localization of TRP53 protein modified form CTD PMID:24560772 , PMID:26193055 cisplatin increases phosphorylation ISO RGD:3889 6480464 Cisplatin results in increased phosphorylation of TP53 protein CTD PMID:33393703 cisplatin increases phosphorylation ISO RGD:70502 6480464 Cisplatin results in increased phosphorylation of TP53 protein CTD PMID:20145152 more ... cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of TRP53 protein CTD PMID:20566416 cisplatin increases response to substance ISO RGD:3889 6480464 TP53 protein results in increased susceptibility to Cisplatin CTD PMID:15315938 cisplatin multiple interactions ISO RGD:3889 6480464 [epigallocatechin gallate co-treated with coenzyme Q10] inhibits the reaction [Cisplatin results in increased phosphorylation of TP53 protein] more ... CTD PMID:15315938 more ... cisplatin increases acetylation ISO RGD:3889 6480464 Cisplatin results in increased acetylation of TP53 protein CTD PMID:21416250 cisplatin increases phosphorylation EXP 6480464 Cisplatin results in increased phosphorylation of TP53 protein, Cisplatin results in increased phosphorylation of TRP53 protein CTD PMID:20883750 more ... cisplatin affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to Cisplatin, TP53 protein modified form affects the susceptibility to Cisplatin CTD PMID:11861384 more ... cisplatin increases response to substance ISO RGD:70502 6480464 TP53 mutant form results in increased susceptibility to Cisplatin more ... CTD PMID:16193384 more ... cisplatin decreases response to substance ISO RGD:70502 6480464 TP53 gene mutant form results in decreased susceptibility to Cisplatin, TP53 protein results in decreased susceptibility to Cisplatin CTD PMID:15578696 more ... cisplatin increases glutathionylation ISO RGD:70502 6480464 Cisplatin results in increased glutathionylation of TP53 protein CTD PMID:17555331 cisplatin increases localization ISO RGD:70502 6480464 Cisplatin results in increased localization of TP53 protein, Cisplatin results in increased localization of TP53 protein mutant form CTD PMID:21109480 cisplatin increases expression ISO RGD:3889 6480464 Cisplatin results in increased expression of TP53 mRNA more ... CTD PMID:20650967 more ... cisplatin increases response to substance EXP 6480464 TRP53 protein results in increased susceptibility to Cisplatin CTD PMID:21552291 cisplatin increases expression ISO RGD:70502 6480464 Cisplatin results in increased expression of TP53 more ... CTD PMID:12082016 more ... cisplatin increases acetylation ISO RGD:70502 6480464 Cisplatin results in increased acetylation of TP53 protein CTD PMID:21532991 cisplatin decreases phosphorylation ISO RGD:70502 6480464 Cisplatin results in decreased phosphorylation of TP53 protein CTD PMID:15854392 cisplatin increases acetylation EXP 6480464 Cisplatin results in increased acetylation of TRP53 protein CTD PMID:21593185 cisplatin affects localization ISO RGD:70502 6480464 Cisplatin affects the localization of TP53 protein CTD PMID:21858171 cisplatin multiple interactions ISO RGD:70502 6480464 2 more ... CTD PMID:12807743 more ... cisplatin multiple interactions EXP 6480464 3-(5-(2 more ... CTD PMID:15983031 more ... cladribine affects activity ISO RGD:70502 6480464 Cladribine affects the activity of TP53 protein, Cladribine metabolite affects the activity of TP53 protein CTD PMID:35435491 clodronic acid affects activity ISO RGD:70502 6480464 Clodronic Acid affects the activity of TP53 protein CTD PMID:25596134 clofarabine multiple interactions ISO RGD:70502 6480464 [resveratrol co-treated with clofarabine] affects the localization of TP53 protein modified form more ... CTD PMID:24239893 clofarabine affects activity ISO RGD:70502 6480464 Clofarabine affects the activity of TP53 protein CTD PMID:35435491 clofibric acid multiple interactions ISO RGD:3889 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TP53 mRNA CTD PMID:17602206 clofibric acid affects expression ISO RGD:3889 6480464 Clofibric Acid affects the expression of TP53 mRNA CTD PMID:17602206 clopidogrel increases expression ISO RGD:70502 6480464 clopidogrel results in increased expression of TP53 mRNA, clopidogrel results in increased expression of TP53 protein CTD PMID:9447704 clotrimazole increases expression ISO RGD:70502 6480464 Clotrimazole results in increased expression of TP53 protein CTD PMID:10223459 clozapine increases expression ISO RGD:70502 6480464 Clozapine results in increased expression of TP53 mRNA CTD PMID:16160616 clozapine multiple interactions ISO RGD:70502 6480464 CSF3 protein inhibits the reaction [Clozapine results in increased expression of TP53 mRNA] CTD PMID:16160616 cobalt atom increases expression ISO RGD:70502 6480464 Cobalt results in increased expression of TP53 protein CTD PMID:21598295 cobalt atom multiple interactions ISO RGD:70502 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of and results in increased stability of TP53 protein more ... CTD PMID:23052192 , PMID:24068677 cobalt dichloride multiple interactions ISO RGD:70502 6480464 3-methyladenine inhibits the reaction [[cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CTSB protein] more ... CTD PMID:10951577 more ... cobalt dichloride increases stability ISO RGD:70502 6480464 cobaltous chloride results in increased stability of TP53 protein CTD PMID:30381462 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of TRP53 mRNA CTD PMID:24265542 cobalt dichloride multiple interactions EXP 6480464 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [cobaltous chloride results in increased expression of TRP53 mRNA] CTD PMID:24265542 cobalt dichloride decreases activity ISO RGD:70502 6480464 cobaltous chloride results in decreased activity of TP53 protein CTD PMID:25446071 cobalt dichloride increases expression ISO RGD:70502 6480464 cobaltous chloride results in increased expression of TP53 mRNA, cobaltous chloride results in increased expression of TP53 protein CTD PMID:20974702 more ... cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of TRP53 mRNA CTD PMID:16772336 cobalt dichloride multiple interactions ISO RGD:3889 6480464 cobaltous chloride promotes the reaction [Diethylnitrosamine results in increased expression of TP53 protein] CTD PMID:11751435 cocaine affects expression EXP 6480464 Cocaine affects the expression of TRP53 mRNA CTD PMID:15681117 coenzyme Q10 multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Cisplatin results in increased expression of TRP53 protein] CTD PMID:20510337 coenzyme Q10 multiple interactions ISO RGD:3889 6480464 [epigallocatechin gallate co-treated with coenzyme Q10] inhibits the reaction [Cisplatin results in increased phosphorylation of TP53 protein] CTD PMID:33393703 colforsin daropate hydrochloride increases expression ISO RGD:70502 6480464 Colforsin results in increased expression of TP53 protein CTD PMID:10642304 colistin multiple interactions ISO RGD:3889 6480464 Anisomycin promotes the reaction [Colistin results in increased expression of TP53 protein], pyrazolanthrone inhibits the reaction [Colistin results in increased expression of TP53 protein] CTD PMID:28842171 colistin increases expression ISO RGD:3889 6480464 Colistin results in increased expression of TP53 protein CTD PMID:28842171 conjugated linoleic acid increases expression ISO RGD:70502 6480464 Linoleic Acids, Conjugated results in increased expression of TP53 protein CTD PMID:15961301 copper atom multiple interactions ISO RGD:70502 6480464 [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene more ... CTD PMID:10334203 more ... copper atom increases expression ISO RGD:70502 6480464 Copper results in increased expression of TP53 protein CTD PMID:15880691 , PMID:20875833 copper atom increases oxidation ISO RGD:70502 6480464 Copper results in increased oxidation of TP53 protein CTD PMID:11964141 copper atom increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to Copper CTD PMID:15880691 copper atom decreases activity ISO RGD:70502 6480464 Copper results in decreased activity of TP53 protein CTD PMID:16246896 copper atom multiple interactions ISO RGD:3889 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of TP53 protein CTD PMID:22276220 copper(0) multiple interactions ISO RGD:70502 6480464 [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene more ... CTD PMID:10334203 more ... copper(0) increases expression ISO RGD:70502 6480464 Copper results in increased expression of TP53 protein CTD PMID:15880691 , PMID:20875833 copper(0) increases oxidation ISO RGD:70502 6480464 Copper results in increased oxidation of TP53 protein CTD PMID:11964141 copper(0) increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to Copper CTD PMID:15880691 copper(0) decreases activity ISO RGD:70502 6480464 Copper results in decreased activity of TP53 protein CTD PMID:16246896 copper(0) multiple interactions ISO RGD:3889 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of TP53 protein CTD PMID:22276220 copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of TRP53 protein CTD PMID:23313662 copper(II) chloride multiple interactions ISO RGD:70502 6480464 [cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein more ... CTD PMID:29803612 copper(II) chloride decreases expression EXP 6480464 cupric chloride results in decreased expression of TRP53 protein CTD PMID:24170445 copper(II) chloride affects expression EXP 6480464 cupric chloride affects the expression of TRP53 mRNA CTD PMID:23313662 copper(II) sulfate multiple interactions ISO RGD:70502 6480464 Copper Sulfate results in increased phosphorylation of and results in increased expression of TP53 protein CTD PMID:15001399 copper(II) sulfate decreases expression ISO RGD:70502 6480464 Copper Sulfate results in decreased expression of TP53 mRNA CTD PMID:27825931 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of TRP53 mRNA CTD PMID:25216733 cordycepin multiple interactions ISO RGD:3889 6480464 ADORA2A mutant form inhibits the reaction [cordycepin results in increased phosphorylation of and results in increased expression of TP53 protein] more ... CTD PMID:23690541 , PMID:24704558 cordycepin increases phosphorylation EXP 6480464 cordycepin results in increased phosphorylation of TRP53 protein CTD PMID:26303320 cordycepin increases expression ISO RGD:70502 6480464 cordycepin results in increased expression of TP53 mRNA CTD PMID:28987792 coumaphos affects activity ISO RGD:70502 6480464 Coumaphos metabolite affects the activity of TP53 protein CTD PMID:35435491 coumarin increases expression ISO RGD:70502 6480464 coumarin analog results in increased expression of TP53 mRNA, coumarin analog results in increased expression of TP53 protein CTD PMID:32578917 coumarin 460 affects activity ISO RGD:70502 6480464 4-methyl-7-diethylaminocoumarin affects the activity of TP53 protein CTD PMID:35435491 cridanimod affects activity ISO RGD:70502 6480464 10-carboxymethyl-9-acridanone affects the activity of TP53 protein, 10-carboxymethyl-9-acridanone metabolite affects the activity of TP53 protein CTD PMID:35435491 crocidolite asbestos decreases expression ISO RGD:70502 6480464 Asbestos more ... CTD PMID:21570478 , PMID:23634900 crocidolite asbestos affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to Asbestos, Crocidolite CTD PMID:9400702 crocidolite asbestos multiple interactions EXP 6480464 OGG1 protein mutant form promotes the reaction [Asbestos, Crocidolite results in increased expression of TRP53 protein] CTD PMID:24918270 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of TRP53 protein CTD PMID:24918270 crocidolite asbestos increases response to substance EXP 6480464 TRP53 gene mutant form results in increased susceptibility to Asbestos, Crocidolite CTD PMID:12151629 , PMID:18303189 crocidolite asbestos increases mutagenesis EXP 6480464 Asbestos, Crocidolite results in increased mutagenesis of TRP53 exon CTD PMID:10992274 crocidolite asbestos increases phosphorylation ISO RGD:70502 6480464 Asbestos, Crocidolite results in increased phosphorylation of TP53 protein CTD PMID:12676607 crocidolite asbestos increases expression ISO RGD:70502 6480464 Asbestos, Crocidolite results in increased expression of TP53 protein CTD PMID:12676607 crocidolite asbestos affects expression ISO RGD:70502 6480464 Asbestos more ... CTD PMID:17331233 , PMID:21570478 crocidolite asbestos multiple interactions ISO RGD:70502 6480464 Asbestos more ... CTD PMID:20705543 , PMID:23634900 crocin-1 multiple interactions EXP 6480464 crocin inhibits the reaction [Paraquat results in increased expression of TRP53 mRNA] CTD PMID:31911963 crotonaldehyde increases expression ISO RGD:3889 6480464 2-butenal results in increased expression of TP53 protein CTD PMID:23535401 Crufomate affects activity ISO RGD:70502 6480464 crufomate metabolite affects the activity of TP53 protein CTD PMID:35435491 cryptolepine increases activity ISO RGD:70502 6480464 cryptolepine results in increased activity of TP53 protein CTD PMID:16120219 cryptolepine increases expression ISO RGD:70502 6480464 cryptolepine results in increased expression of TP53 protein CTD PMID:16120219 crystal violet multiple interactions ISO RGD:70502 6480464 Gentian Violet inhibits the reaction [NOX1 protein results in decreased activity of TP53 protein] more ... CTD PMID:24535435 crystal violet affects activity ISO RGD:70502 6480464 Gentian Violet affects the activity of TP53 protein CTD PMID:35435491 CU-O LINKAGE multiple interactions ISO RGD:70502 6480464 cupric oxide analog results in decreased phosphorylation of and results in decreased expression of TP53 protein CTD PMID:25336953 CU-O LINKAGE decreases expression ISO RGD:70502 6480464 cupric oxide results in decreased expression of TP53 mRNA CTD PMID:22077320 , PMID:32285662 CU-O LINKAGE multiple interactions EXP 6480464 cupric oxide analog results in decreased phosphorylation of and results in decreased expression of TRP53 protein CTD PMID:25336953 cudraflavone B increases expression ISO RGD:70502 6480464 cudraflavone B results in increased expression of TP53 protein CTD PMID:23881456 cudraflavone B multiple interactions ISO RGD:70502 6480464 resveratrol inhibits the reaction [cudraflavone B results in increased expression of TP53 protein], sirtinol promotes the reaction [cudraflavone B results in increased expression of TP53 protein] CTD PMID:23881456 Cuprizon increases expression ISO RGD:3889 6480464 Cuprizone results in increased expression of TP53 mRNA CTD PMID:26577399 , PMID:27523638 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of TRP53 mRNA, Cuprizone results in increased expression of TRP53 protein CTD PMID:18550754 Cuprizon decreases response to substance EXP 6480464 TRP53 protein mutant form results in decreased susceptibility to Cuprizone CTD PMID:18550754 curcumin multiple interactions ISO RGD:70502 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of TP53 protein more ... CTD PMID:19020741 more ... curcumin decreases expression ISO RGD:70502 6480464 Curcumin analog results in decreased expression of TP53 mRNA more ... CTD PMID:26409325 more ... curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of TP53 protein CTD PMID:22714040 curcumin multiple interactions EXP 6480464 [Curcumin co-treated with Quercetin] inhibits the reaction [Benzo(a)pyrene results in decreased acetylation of TRP53 protein] more ... CTD PMID:21519798 more ... curcumin increases expression EXP 6480464 Curcumin results in increased expression of TRP53 mRNA CTD PMID:25822711 curcumin increases expression ISO RGD:70502 6480464 [Curcumin results in increased expression of SERPINB5] which results in increased expression of TP53 protein more ... CTD PMID:19944674 more ... curcumin multiple interactions ISO RGD:3889 6480464 [Curcumin binds to carboxymethyl-chitosan analog] inhibits the reaction [AGT protein modified form results in decreased degradation of TP53 protein] more ... CTD PMID:19227835 more ... curcumin increases phosphorylation ISO RGD:70502 6480464 Curcumin results in increased phosphorylation of TP53 protein CTD PMID:17332930 more ... curcumin increases acetylation ISO RGD:70502 6480464 Curcumin results in increased acetylation of TP53 protein CTD PMID:17332930 curcumin affects expression ISO RGD:70502 6480464 Curcumin affects the expression of TP53 protein more ... CTD PMID:17041101 , PMID:24211270 curcumin affects localization ISO RGD:70502 6480464 Curcumin affects the localization of TP53 protein CTD PMID:17332930 cyanamide multiple interactions ISO RGD:3889 6480464 [Ethanol co-treated with Cyanamide] results in increased expression of TP53 mRNA CTD PMID:12003908 cycloheximide increases response to substance ISO RGD:70502 6480464 TP53 mutant form results in increased susceptibility to Cycloheximide CTD PMID:21875941 cycloheximide decreases expression ISO RGD:70502 6480464 Cycloheximide results in decreased expression of TP53 protein CTD PMID:20943951 cycloheximide increases degradation ISO RGD:70502 6480464 Cycloheximide results in increased degradation of TP53 protein CTD PMID:31645432 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Cyclosporine results in increased expression of TRP53 protein] CTD PMID:10760090 cycloheximide multiple interactions ISO RGD:3889 6480464 Cycloheximide inhibits the reaction [TGFB1 protein results in increased expression of TP53 protein] CTD PMID:9790906 cycloheximide multiple interactions ISO RGD:70502 6480464 Cycloheximide inhibits the reaction [Fluorouracil results in increased expression of TP53 protein] more ... CTD PMID:15016801 more ... cyclophosphamide multiple interactions ISO RGD:3889 6480464 astaxanthine inhibits the reaction [Cyclophosphamide results in increased expression of TP53 protein] more ... CTD PMID:19227835 more ... cyclophosphamide increases activity ISO RGD:70502 6480464 Cyclophosphamide metabolite results in increased activity of TP53 protein CTD PMID:20655369 , PMID:22010212 cyclophosphamide multiple interactions ISO RGD:70502 6480464 TP53 protein promotes the reaction [Methotrexate results in increased susceptibility to Cyclophosphamide metabolite] CTD PMID:22010212 cyclophosphamide increases expression ISO RGD:3889 6480464 Cyclophosphamide results in increased expression of TP53 mRNA, Cyclophosphamide results in increased expression of TP53 protein CTD PMID:20038455 , PMID:32197949 cyclophosphamide increases mutagenesis ISO RGD:70502 6480464 Cyclophosphamide results in increased mutagenesis of TP53 exon CTD PMID:9610789 cyclophosphamide affects response to substance EXP 6480464 TRP53 affects the susceptibility to Cyclophosphamide CTD PMID:10766175 cyclophosphamide increases mutagenesis ISO RGD:3889 6480464 Cyclophosphamide results in increased mutagenesis of TP53 exon CTD PMID:19227835 cyclophosphamide affects response to substance ISO RGD:70502 6480464 TP53 protein affects the susceptibility to Cyclophosphamide CTD PMID:15182437 cyclosporin A increases expression ISO RGD:70502 6480464 Cyclosporine results in increased expression of TP53 mRNA CTD PMID:20106945 cyclosporin A affects expression ISO RGD:3889 6480464 Cyclosporine affects the expression of TP53 protein CTD PMID:24971338 cyclosporin A affects activity ISO RGD:3889 6480464 Cyclosporine affects the activity of TP53 protein CTD PMID:25596134 cyclosporin A affects activity ISO RGD:70502 6480464 Cyclosporine affects the activity of TP53 protein CTD PMID:25596134 cyclosporin A multiple interactions ISO RGD:70502 6480464 [Cyclosporine co-treated with NGF protein] results in increased expression of TP53 mRNA more ... CTD PMID:24244623 more ... cyclosporin A increases expression ISO RGD:3889 6480464 Cyclosporine results in increased expression of TP53, Cyclosporine results in increased expression of TP53 mRNA CTD PMID:24971338 , PMID:25299210 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of TRP53 protein CTD PMID:10760090 cyclosporin A multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Cyclosporine results in increased expression of TRP53 protein] more ... CTD PMID:10205001 more ... cyfluthrin increases expression ISO RGD:70502 6480464 cyfluthrin results in increased expression of TP53 mRNA CTD PMID:31330490 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of TRP53 mRNA CTD PMID:20097460 cylindrospermopsin increases expression ISO RGD:3889 6480464 cylindrospermopsin results in increased expression of TP53 mRNA, cylindrospermopsin results in increased expression of TP53 protein CTD PMID:34687773 cypermethrin increases expression ISO RGD:3889 6480464 cypermethrin results in increased expression of TP53 mRNA, cypermethrin results in increased expression of TP53 protein CTD PMID:22528246 , PMID:24759048 cypermethrin multiple interactions ISO RGD:70502 6480464 Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA] CTD PMID:29945211 cypermethrin increases expression ISO RGD:70502 6480464 cypermethrin results in increased expression of TP53 mRNA CTD PMID:29945211 more ... cypermethrin increases mutagenesis ISO RGD:70502 6480464 cypermethrin results in increased mutagenesis of TP53 exon CTD PMID:28584332 cypermethrin decreases expression ISO RGD:70502 6480464 cypermethrin results in decreased expression of TP53 mRNA CTD PMID:27704156 cypermethrin multiple interactions ISO RGD:3889 6480464 Vitamin E inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA] CTD PMID:24759048 cytarabine multiple interactions ISO RGD:70502 6480464 [fludarabine co-treated with Cytarabine co-treated with docetaxel] results in increased expression of TP53 protein more ... CTD PMID:17977830 , PMID:9703875 cytarabine affects activity ISO RGD:70502 6480464 Cytarabine affects the activity of TP53 protein, Cytarabine metabolite affects the activity of TP53 protein CTD PMID:35435491 cytarabine increases activity ISO RGD:70502 6480464 Cytarabine results in increased activity of TP53 protein CTD PMID:22010212 cytarabine affects response to substance EXP 6480464 TRP53 protein affects the susceptibility to Cytarabine CTD PMID:20477944 cytarabine increases response to substance ISO RGD:70502 6480464 TP53 gene mutant form results in increased susceptibility to Cytarabine CTD PMID:24675086 cytarabine increases expression ISO RGD:70502 6480464 [Cytarabine results in increased expression of TP53 protein] which results in increased expression of BAX protein, Cytarabine results in increased expression of TP53 protein CTD PMID:10200513 more ... cytarabine increases expression ISO RGD:3889 6480464 Cytarabine results in increased expression of TP53 protein CTD PMID:14766721 more ... cytarabine increases phosphorylation ISO RGD:70502 6480464 Cytarabine results in increased phosphorylation of TP53 protein CTD PMID:10200513 more ... cytochalasin B increases expression ISO RGD:70502 6480464 Cytochalasin B results in increased expression of TP53 protein CTD PMID:27640744 D-glucose multiple interactions ISO RGD:70502 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein]] more ... CTD PMID:20068143 more ... D-glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein more ... CTD PMID:28675767 D-glucose increases expression ISO RGD:70502 6480464 Glucose results in increased expression of TP53 mRNA, Glucose results in increased expression of TP53 protein CTD PMID:26188290 more ... D-glucose multiple interactions ISO RGD:3889 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] more ... CTD PMID:23451161 , PMID:25997894 D-glucose increases acetylation ISO RGD:70502 6480464 Glucose results in increased acetylation of TP53 protein CTD PMID:20068143 D-glucose affects localization ISO RGD:70502 6480464 Glucose affects the localization of TP53 protein CTD PMID:24218232 D-mannitol multiple interactions ISO RGD:70502 6480464 Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein] CTD PMID:29803612 D-penicillamine increases expression ISO RGD:70502 6480464 Penicillamine results in increased expression of TP53 protein CTD PMID:22843330 D-penicillamine decreases expression ISO RGD:70502 6480464 Penicillamine results in decreased expression of TP53 mRNA CTD PMID:22843330 daidzein increases expression ISO RGD:70502 6480464 daidzein results in increased expression of TP53 protein CTD PMID:19800779 dapagliflozin multiple interactions ISO RGD:3889 6480464 dapagliflozin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of TP53 protein] CTD PMID:34391751 DAPT decreases expression ISO RGD:70502 6480464 N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein CTD PMID:25005833 DAPT multiple interactions ISO RGD:70502 6480464 Hydrogen Peroxide inhibits the reaction [N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein] CTD PMID:25005833 daunorubicin multiple interactions ISO RGD:70502 6480464 [Daunorubicin co-treated with Magnetite Nanoparticles] results in increased activity of TP53 protein, Daunorubicin results in increased phosphorylation of and results in increased expression of TP53 protein CTD PMID:21518493 , PMID:23872705 daunorubicin affects activity ISO RGD:70502 6480464 Daunorubicin affects the activity of TP53 protein CTD PMID:35435491 daunorubicin increases activity ISO RGD:70502 6480464 Daunorubicin results in increased activity of TP53 protein CTD PMID:12112851 daunorubicin increases expression ISO RGD:70502 6480464 Daunorubicin results in increased expression of TP53 mRNA CTD PMID:12656675 DDE increases expression ISO RGD:70502 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of TP53 mRNA CTD PMID:19545618 DDE increases activity ISO RGD:70502 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of TP53 protein CTD PMID:27589886 DDT multiple interactions EXP 6480464 DDT inhibits the reaction [TRP53 protein binds to CDKN1A promoter] CTD PMID:23684557 DDT decreases expression ISO RGD:3889 6480464 DDT results in decreased expression of TP53 mRNA, DDT results in decreased expression of TP53 protein CTD PMID:25410620 DDT increases methylation ISO RGD:3889 6480464 DDT results in increased methylation of TP53 promoter CTD PMID:25410620 DDT decreases expression EXP 6480464 DDT results in decreased expression of TRP53 protein CTD PMID:23684557 deguelin decreases expression ISO RGD:70502 6480464 [deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of TP53 protein, deguelin results in decreased expression of TP53 mRNA CTD PMID:22227970 , PMID:25242579 deguelin increases expression ISO RGD:70502 6480464 deguelin results in increased expression of TP53 mRNA CTD PMID:33512557 dehydroepiandrosterone increases expression ISO RGD:70502 6480464 Dehydroepiandrosterone results in increased expression of TP53 mRNA CTD PMID:15752352 deoxycholic acid increases expression ISO RGD:3889 6480464 Deoxycholic Acid results in increased expression of TP53 mRNA CTD PMID:20137712 deoxycholic acid multiple interactions ISO RGD:3889 6480464 TP53 protein affects the reaction [[Deoxycholic Acid results in increased expression of CCND1 protein] which affects the localization of BAX protein], Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of TP53 mRNA] CTD PMID:17431217 , PMID:20137712 Deoxycorticosterone acetate multiple interactions ISO RGD:3889 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of TP53 mRNA CTD PMID:22228705 deoxynivalenol multiple interactions EXP 6480464 [pifithrin results in decreased activity of TP53 protein] which results in decreased susceptibility to deoxynivalenol more ... CTD PMID:15976193 more ... deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of TRP53 protein CTD PMID:35817260 deoxynivalenol decreases expression ISO RGD:70502 6480464 deoxynivalenol results in decreased expression of TP53 protein CTD PMID:33890134 deoxynivalenol multiple interactions ISO RGD:70502 6480464 [Zearalenone co-treated with Aflatoxin B1] promotes the reaction [deoxynivalenol results in increased expression of TP53 mRNA], Aflatoxin B1 promotes the reaction [deoxynivalenol results in increased expression of TP53 mRNA] CTD PMID:30668976 deoxynivalenol increases expression ISO RGD:70502 6480464 deoxynivalenol results in increased expression of TP53 mRNA CTD PMID:30668976 deoxynivalenol increases activity ISO RGD:70502 6480464 deoxynivalenol results in increased activity of TP53 protein CTD PMID:19664677 Deoxyschizandrin multiple interactions ISO RGD:70502 6480464 MEG3 protein affects the reaction [schizandrin A results in increased expression of TP53 protein] CTD PMID:32057180 Deoxyschizandrin increases expression ISO RGD:70502 6480464 schizandrin A results in increased expression of TP53 protein CTD PMID:32057180 dequalinium increases expression ISO RGD:70502 6480464 Dequalinium results in increased expression of TP53 protein CTD PMID:21548882 desferrioxamine B multiple interactions ISO RGD:70502 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA more ... CTD PMID:10942736 more ... desferrioxamine B increases expression ISO RGD:70502 6480464 Deferoxamine results in increased expression of TP53 protein CTD PMID:23483119 desferrioxamine B decreases response to substance ISO RGD:70502 6480464 TP53 protein results in decreased susceptibility to Deferoxamine CTD PMID:16527254 dexamethasone multiple interactions ISO RGD:70502 6480464 Dexamethasone inhibits the reaction [TP53 protein binds to FPR1 promoter] CTD PMID:19037090 dexamethasone increases activity ISO RGD:70502 6480464 Dexamethasone results in increased activity of TP53 protein CTD PMID:22010212 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TRP53 protein] CTD PMID:15987750 dexamethasone decreases expression ISO RGD:3889 6480464 Dexamethasone results in decreased expression of TP53 mRNA CTD PMID:17522070 dexamethasone decreases expression ISO RGD:70502 6480464 Dexamethasone results in decreased expression of TP53 protein CTD PMID:19037090 dexmedetomidine multiple interactions ISO RGD:3889 6480464 atipamezole inhibits the reaction [Dexmedetomidine inhibits the reaction [lipopolysaccharide more ... CTD PMID:30597158 dextran sulfate increases expression EXP 6480464 Dextran Sulfate results in increased expression of TRP53 protein CTD PMID:16049979 Diacetoxyscirpenol decreases expression EXP 6480464 diacetoxyscirpenol results in decreased expression of TRP53 mRNA CTD PMID:31836554 Dialifor affects activity ISO RGD:70502 6480464 dialifor metabolite affects the activity of TP53 protein CTD PMID:35435491 diallyl disulfide multiple interactions ISO RGD:70502 6480464 Acetylcysteine inhibits the reaction [diallyl disulfide results in increased expression of TP53 protein] more ... CTD PMID:11925476 , PMID:19202565 diallyl disulfide multiple interactions ISO RGD:3889 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of TP53 mRNA CTD PMID:31077537 diallyl disulfide increases expression ISO RGD:70502 6480464 diallyl disulfide results in increased expression of TP53 protein CTD PMID:11925476 , PMID:19202565 Diallyl sulfide increases expression ISO RGD:3889 6480464 allyl sulfide results in increased expression of TP53 mRNA CTD PMID:17125941 Diallyl sulfide increases expression ISO RGD:70502 6480464 allyl sulfide results in increased expression of TP53 mRNA CTD PMID:24650757 Diallyl sulfide multiple interactions ISO RGD:3889 6480464 [allyl sulfide co-treated with Diethylstilbestrol] results in increased expression of TP53 mRNA CTD PMID:17125941 diallyl trisulfide increases expression ISO RGD:70502 6480464 diallyl trisulfide results in increased expression of TP53 mRNA, diallyl trisulfide results in increased expression of TP53 protein CTD PMID:19823037 more ... diallyl trisulfide multiple interactions ISO RGD:70502 6480464 diallyl trisulfide results in increased expression of and affects the localization of TP53 protein CTD PMID:19823037 diallyl trisulfide affects localization ISO RGD:70502 6480464 diallyl trisulfide affects the localization of TP53 protein CTD PMID:24415872 diarsenic trioxide increases degradation ISO RGD:70502 6480464 Arsenic Trioxide results in increased degradation of TP53 protein CTD PMID:19457607 diarsenic trioxide increases activity ISO RGD:3889 6480464 Arsenic Trioxide results in increased activity of TP53 protein CTD PMID:17487067 diarsenic trioxide increases phosphorylation ISO RGD:3889 6480464 Arsenic Trioxide results in increased phosphorylation of TP53 protein CTD PMID:23337567 diarsenic trioxide decreases expression ISO RGD:70502 6480464 Arsenic Trioxide results in decreased expression of TP53 mRNA more ... CTD PMID:21454520 more ... diarsenic trioxide increases phosphorylation ISO RGD:70502 6480464 Arsenic Trioxide results in increased phosphorylation of TP53 protein CTD PMID:29944906 , PMID:30472098 diarsenic trioxide multiple interactions ISO RGD:3889 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of TP53 protein] more ... CTD PMID:17487067 more ... diarsenic trioxide affects response to substance ISO RGD:70502 6480464 TP53 affects the susceptibility to Arsenic Trioxide, TP53 protein affects the susceptibility to Arsenic Trioxide CTD PMID:12851490 , PMID:29535630 diarsenic trioxide increases phosphorylation EXP 6480464 Arsenic Trioxide results in increased phosphorylation of TP53 protein CTD PMID:27638049 diarsenic trioxide increases expression ISO RGD:3889 6480464 Arsenic Trioxide results in increased expression of TP53 mRNA, Arsenic Trioxide results in increased expression of TP53 protein CTD PMID:21145380 more ... diarsenic trioxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in increased phosphorylation of TRP53 protein] more ... CTD PMID:21565247 , PMID:27638049 diarsenic trioxide affects expression ISO RGD:70502 6480464 Arsenic Trioxide affects the expression of TP53 CTD PMID:11775218 diarsenic trioxide increases expression ISO RGD:70502 6480464 Arsenic Trioxide results in increased expression of TP53 mRNA more ... CTD PMID:10841286 more ... diarsenic trioxide decreases response to substance ISO RGD:70502 6480464 TP53 protein mutant form results in decreased susceptibility to Arsenic Trioxide CTD PMID:21454520 , PMID:24884809 diarsenic trioxide multiple interactions ISO RGD:70502 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of TP53 protein more ... CTD PMID:12851490 more ... diazinon increases expression ISO RGD:3889 6480464 Diazinon results in increased expression of TP53 mRNA CTD PMID:17452286 diazinon multiple interactions ISO RGD:70502 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TP53 mRNA], Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of TP53 mRNA] CTD PMID:27920530 diazinon increases expression ISO RGD:70502 6480464 Diazinon results in increased expression of TP53 mRNA CTD PMID:27920530 diazinon affects expression ISO RGD:3889 6480464 Diazinon affects the expression of TP53 mRNA CTD PMID:22546817 diazoxide decreases expression ISO RGD:3889 6480464 Diazoxide results in decreased expression of TP53 mRNA CTD PMID:16426753 diazoxon affects activity ISO RGD:70502 6480464 diazoxon metabolite affects the activity of TP53 protein CTD PMID:35435491 dibenz[a,h]anthracene multiple interactions ISO RGD:70502 6480464 TP53 protein affects the reaction [1 more ... CTD PMID:25398514 dibenz[a,h]anthracene increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to 1 more ... CTD PMID:25398514 Dibenzo[a,e]pyrene increases phosphorylation ISO RGD:3889 6480464 dibenzo(a, e)pyrene results in increased phosphorylation of TP53 protein CTD PMID:17961608 dibenzo[a,l]pyrene multiple interactions ISO RGD:70502 6480464 2 more ... CTD PMID:24954032 , PMID:25398514 dibenzo[a,l]pyrene increases response to substance ISO RGD:70502 6480464 TP53 protein results in increased susceptibility to dibenzo(a, l)pyrene CTD PMID:25398514 dibenzo[a,l]pyrene increases phosphorylation ISO RGD:3889 6480464 dibenzo(a, l)pyrene results in increased phosphorylation of TP53 protein CTD PMID:16005925 , PMID:17961608 dibenzo[a,l]pyrene increases expression ISO RGD:70502 6480464 dibenzo(a, l)pyrene results in increased expression of TP53 protein CTD PMID:15548639 dibenzo[a,l]pyrene increases expression EXP 6480464 dibenzo(a, l)pyrene results in increased expression of TRP53 protein CTD PMID:20353797 dibenzo[a,l]pyrene multiple interactions EXP 6480464 [dibenzo(a, l)pyrene co-treated with sodium arsenite] results in increased expression of TRP53 protein CTD PMID:20353797 dibenzo[a,l]pyrene multiple interactions ISO RGD:3889 6480464 pifithrin inhibits the reaction [dibenzo(a more ... CTD PMID:16005925 Dibutyl phosphate affects binding ISO RGD:70502 6480464 di-n-butylphosphoric acid binds to TP53 gene CTD PMID:25510514 dibutyl phthalate increases expression ISO RGD:3889 6480464 Dibutyl Phthalate results in increased expression of TP53 protein CTD PMID:28067064 dibutyl phthalate increases methylation ISO RGD:70502 6480464 Dibutyl Phthalate results in increased methylation of TP53 promoter CTD PMID:35487445 dibutyl phthalate decreases expression ISO RGD:70502 6480464 Dibutyl Phthalate results in decreased expression of TP53 mRNA CTD PMID:35487445 dichlorine increases expression ISO RGD:70502 6480464 Chlorine results in increased expression of TP53 protein modified form CTD PMID:35065218 dichlorine multiple interactions ISO RGD:70502 6480464 Acetylcysteine promotes the reaction [Chlorine results in increased expression of TP53 protein modified form] CTD PMID:35065218 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of TRP53 protein CTD PMID:22705712 Dichlorophen affects activity ISO RGD:70502 6480464 Dichlorophen affects the activity of TP53 protein CTD PMID:35435491 dichlorvos decreases expression ISO RGD:3889 6480464 Dichlorvos results in decreased expression of TP53 mRNA CTD PMID:23053939 dichlorvos increases expression ISO RGD:3889 6480464 Dichlorvos results in increased expression of TP53 mRNA, Dichlorvos results in increased expression of TP53 protein CTD PMID:24369695 dichlorvos multiple interactions ISO RGD:3889 6480464 TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of TP53 mRNA], TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of TP53 protein] CTD PMID:24369695 dichromic acid increases expression ISO RGD:70502 6480464 chromic acid results in increased expression of TP53 mRNA CTD PMID:27005777 diclofenac multiple interactions EXP 6480464 Diclofenac promotes the reaction [Doxorubicin results in increased expression of TRP53 protein] CTD PMID:15458769 diclofenac increases expression ISO RGD:3889 6480464 Diclofenac results in increased expression of TP53 mRNA CTD PMID:29027214 diclofenac increases expression ISO RGD:70502 6480464 Diclofenac results in increased expression of TP53 mRNA, Diclofenac results in increased expression of TP53 protein CTD PMID:29027214 , PMID:32087850 diclofenac affects expression ISO RGD:70502 6480464 Diclofenac affects the expression of TP53 mRNA CTD PMID:24752500 dicoumarol multiple interactions ISO RGD:70502 6480464 Dicumarol inhibits the reaction [2 more ... CTD PMID:14634213 more ... dicoumarol decreases expression ISO RGD:70502 6480464 Dicumarol results in decreased expression of TP53 protein CTD PMID:22692362 dicoumarol increases degradation ISO RGD:70502 6480464 Dicumarol results in increased degradation of TP53 protein CTD PMID:14634213 dicrotophos increases expression ISO RGD:70502 6480464 dicrotophos results in increased expression of TP53 mRNA CTD PMID:28302478 dicrotophos affects activity ISO RGD:70502 6480464 dicrotophos metabolite affects the activity of TP53 protein CTD PMID:35435491 Dictamnine increases expression ISO RGD:70502 6480464 dictamnine results in increased expression of TP53 protein CTD PMID:34861243 Didecyldimethylammonium increases expression ISO RGD:70502 6480464 didecyldimethylammonium results in increased expression of TP53 protein modified form CTD PMID:32763356 dieckol multiple interactions EXP 6480464 dieckol inhibits the reaction [9 more ... CTD PMID:33347706 dieldrin affects expression ISO RGD:3889 6480464 Dieldrin affects the expression of TP53 mRNA CTD PMID:22546817 dieldrin decreases response to substance ISO RGD:70502 6480464 TP53 gene mutant form results in decreased susceptibility to Dieldrin CTD PMID:32421776 dieldrin increases activity EXP 6480464 Dieldrin results in increased activity of TRP53 protein CTD PMID:22634143 dienestrol affects activity ISO RGD:70502 6480464 Dienestrol affects the activity of TP53 protein CTD PMID:35435491 diepoxybutane increases expression ISO RGD:70502 6480464 diepoxybutane results in increased expression of TP53 protein CTD PMID:14998682 diepoxybutane increases phosphorylation ISO RGD:70502 6480464 diepoxybutane results in increased phosphorylation of TP53 protein CTD PMID:29405768 diepoxybutane multiple interactions ISO RGD:70502 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diepoxybutane results in increased phosphorylation of TP53 protein] more ... CTD PMID:20024960 more ... diethanolamine decreases expression EXP 6480464 diethanolamine results in decreased expression of TRP53 mRNA CTD PMID:16014740 diethanolamine decreases expression ISO RGD:3889 6480464 diethanolamine results in decreased expression of TP53 mRNA CTD PMID:16014740 diethyl maleate multiple interactions EXP 6480464 TRP53 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] CTD PMID:22003191 diethyl maleate multiple interactions ISO RGD:70502 6480464 TP53 protein affects the reaction [diethyl maleate results in increased expression of CDKN1A protein], TP53 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein] CTD PMID:27982581 diethyl sulfate increases expression ISO RGD:70502 6480464 diethyl sulfate results in increased expression of TP53 protein CTD PMID:23830811 diethyl sulfate decreases expression ISO RGD:70502 6480464 diethyl sulfate results in decreased expression of TP53 protein CTD PMID:23830811 diethyldithiocarbamic acid increases expression ISO RGD:70502 6480464 Ditiocarb results in increased expression of TP53 protein CTD PMID:11964141 diethyldithiocarbamic acid multiple interactions ISO RGD:70502 6480464 Ditiocarb inhibits the reaction [cobaltous chloride results in increased expression of and results in increased activity of TP53 protein], Ditiocarb inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein] CTD PMID:10951577 diethylstilbestrol multiple interactions ISO RGD:3889 6480464 [allyl sulfide co-treated with Diethylstilbestrol] results in increased expression of TP53 mRNA CTD PMID:17125941 diethylstilbestrol decreases expression ISO RGD:70502 6480464 Diethylstilbestrol results in decreased expression of TP53 mRNA CTD PMID:27825931 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of TRP53 mRNA, Diethylstilbestrol results in increased expression of TRP53 protein CTD PMID:15545218 more ... diethylstilbestrol affects response to substance EXP 6480464 TRP53 affects the susceptibility to Diethylstilbestrol CTD PMID:15545218 diethylstilbestrol increases expression ISO RGD:3889 6480464 Diethylstilbestrol results in increased expression of TP53 mRNA CTD PMID:17011747 diethylstilbestrol decreases expression ISO RGD:3889 6480464 Diethylstilbestrol results in decreased expression of TP53 mRNA CTD PMID:17125941 digitoxin decreases expression ISO RGD:70502 6480464 Digitoxin analog results in decreased expression of TP53 protein, Digitoxin results in decreased expression of TP53 protein CTD PMID:22037315 dihydroartemisinin increases phosphorylation ISO RGD:70502 6480464 artenimol results in increased phosphorylation of TP53 protein CTD PMID:21547369 dihydroartemisinin multiple interactions ISO RGD:70502 6480464 artenimol inhibits the reaction [TP53 protein mutant form results in increased export of Doxorubicin] more ... CTD PMID:31976328 dihydrocapsaicin increases phospho 
